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1 Introduction 
 
Traditional medicinal systems, especially of Asian origin, have become more 
interesting in Western countries during the last decades. Traditional Chinese 
Medicine, Ayurveda and Traditional Tibetan Medicine are popular ones, which 
are often applied to patients in many European countries as alternative 
(complementary) medical treatment. Rather unknown is the Traditional 
Mongolian Medicine (TMM). Considering the Mongolian history there has been 
an increasing interest in traditional Mongolian medicine since the beginning of 
the 1990s. This led to scientific investigations in this ancient medical system not 
only within Mongolia, but also together with foreign academic institutions in 
Asian and Western countries. Among the new academic partners were also 
various universities in Austria, and one of them is the Department of 
Pharmacognosy in Vienna [1].  
 
1.1 Traditional Mongolian Medicine 
 
Literature about TMM is scarce and mostly written in Mongolian or Russian. 
However, some books are also edited in English and some interesting 
information about the Mongolian health system and the use of traditional 
medicine during the last decade is compiled in reports available in online-
databases [2, 3, 4, 5]. The next chapters provide a comprehensive overview 
about the available literature and refer to the following topics: Historical 
background of TMM, principles of TMM, traditional medicinal preparations, the 
Mongolian health care system, and the health situation in Mongolia. 
 
1.1.1 Historical background of TMM 
 
TMM developed from Mongolian folk medicine and was highly influenced by the 
Traditional Tibetan Medicine and Ayurveda. During the 13th century, Mongolia 
came under the missionary influence of Lamaism. Its sciences of healing, which 
initially were just healing practises, were established and developed gradually. 
Medical practitioners were called from Tibet to Mongolia as court physicians 
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and independent medical schools developed in Mongolia, even though under 
Tibetan names [6]. Traditional Mongolian medical knowledge was transmitted 
over generations in various ways: through private practitioners who got their 
medical knowledge from the elders and through educational and faculty 
systems which were established in the 16th century. “Manba Datsan” is the 
general name for a Buddhistic monastic school of traditional medicine, mostly 
designed to educate physicians but also to provide scientific studies for scholars 
of various subjects [7]. In 1921 Mongolia declared independence from China 
and, in 1924, the Mongolian People's Revolutionary Party established the 
People's Republic of Mongolia. The Communists' system of the Soviet Union 
gained more and more influence on Mongolian politics, and in 1936 the 
Mongolian republic entered into an alliance with the Soviets. This communist 
influence caused dramatic changes in political and social structures. Lamaism, 
the religion which had dominated until then was banned officially. In 1937 the 
destruction of monasteries and persecution of monks started and led to a 
collapse of religious institutions and, subsequently, also to a come down of 
traditional medicine [1]. Finally, the last Tibetan pharmacy in Mongolia was 
closed officially, and Western medicine became the only permitted possibility of 
medical treatment [2]. For a long time it was forbidden to practise the ancient 
Mongolian medicine. However, traditional medicine was still popular and used 
secretly, especially in the treatment of chronic diseases. After the political 
changes in the Soviet system at the beginning of the 1990s the restrictions were 
lifted and Mongolian medicine became officially recognized as its own 
Mongolian heritage [1]. During the 1990s the state policy of the new Mongolian 
government focused on the revival of Buddhism and TMM. A new Manba 
Datsan including a hospital and training centre with the aim to restore TMM in 
the country was founded [7]. In 1991 the Otoch Manramba Medical College at 
this respective Manba Datsan was established in order to provide training 
courses in traditional Mongolian medicine. This institution aims at combining 
traditional methods of treatment with the modern achievement of biomedicine. 
Besides training activities, the college is pursuing research and maintains 
regular contact with other medical research institutions, e.g. in India, Japan, 
USA, Switzerland, UK, Germany, and Austria [7]. Another institution, the School 
of Traditional Medicine of the Health Sciences University of Mongolia, offers all 
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degrees of education in traditional medicine and promotes research in this field. 
As a consequence of those efforts, today, various hospitals and clinics apply 
western as well as traditional methods. Furthermore, many small clinics, which 
offer special traditional treatments, have been established throughout the 
country during the last decades. By 2007, the number of people who received 
traditional medicinal health care reached 23.6% of the total population [2]. 
 
1.1.2 Principles of Traditional Mongolian Medicine 
 
The basics of TMM follow mainly the guidelines of Traditional Tibetan Medicine 
and Tibetan Buddhism. Although there exists a variety of ancient medical 
treatises written by Mongolians, traditional doctors accept the main Tibetan 
medical treatise, the rgyud bzhi (Dürben Ündüsün in Mongolian), literally "The 
Four Roots", as the basis of their medical knowledge [1, 6]. According to 
traditional medicine, the human body is seen as an entity and health relies on 
the equilibrium of the three life sustaining principles, named in Mongolian hii 
(Tibetan rlung), šar (Tibetan mkhris pa) and badgan (Tibetan bad kan). Any 
disturbance in the equilibrium of the three principles results in a disease. 
Therefore, traditional medical treatment focuses on the re-establishment of this 
equilibrium. Pulse reading, tongue examination, urine check (smell, taste, and 
colour) and interrogation of the patient serve as diagnosis parameters. It has to 
be kept in mind that traditional methods of diagnosis do not necessarily 
correlate with diseases as classified in Western medicine. In general, TMM 
differentiates hot and cold disorders. Regarding liver impairment, there are 13 
hot disorders and 5 cold ones. However, some symptoms listed in the traditional 
texts relate to Western disease syndromes. E.g. fever, localisation of pain, and 
yellow skin are mentioned as symptoms which indicate a liver involvement. The 
therapy of diseases, according to traditional medicine, focuses first on changes 
in the patient's diet and behaviour in daily life. Other therapeutic measures are 
medication, massages, blood-letting, steam baths, acupuncture, and 
moxibustion. The medical preparations are usually complex mixtures of a 
varying number of ingredients, mainly plants but also minerals and animal drugs. 
In general, one ingredient is specified as the leading one, while the remaining 
ones support the main ingredient in its efficacy. A specific nature and particular 
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qualities as well as secondary qualities, which influence the three life sustaining 
principles in the human body, are assigned to each ingredient. In general, hot 
diseases are treated with medicines having a cooling nature, whereas cold 
diseases require a treatment with medicines of warming qualities. Furthermore, 
it is very important, that the qualities and second qualities of the ingredients are 
well balanced because otherwise the medicine may have an adverse effect on 
the patient instead of a favourable one [1]. 
 
1.1.3 Traditional Mongolian medicinal preparations 
 
The three main types of traditional medicines in Mongolia are available in the 
form of talkh, tan, and pills. The tan preparation is a traditional medicinal drug 
preparation at a pulverization level of 0.5-2 mm. It consists of either a single 
component or a combination of several ingredients. The ingredients are 
selected separately and cleaned, then blended and pulverized. This kind of 
preparation is boiled or macerated with water, milk or soup. In 2006 about 32% 
of the total amount of traditional medicines was tan preparations [2]. The talkh 
preparation, which is the most common form of traditional preparations (50% of 
total preparations in 2006), consists of a single component or a mixture of 
ingredients but, compared to tan preparations, the pulverization level is 0.125-
0.315 mm. Talkh preparations are applied topically or internally, with water, milk 
or soup [2]. For the preparation of pills the finely powdered medicine is mixed 
with a suitable excipient such as water, honey, molasses or other liquids. Pills 
can be coated or uncoated and are usually taken with water, milk or soup. Pill 
preparations play a minor role and amounted only to 6% of the total number of 
manufactured preparations in 2006 [2]. In the past, each traditional physician 
prepared the medicines for his patients himself according to the prescriptions of 
medical texts or his own experience. Also the necessary plants, minerals, and 
animal products for certain medications were collected by the physician himself. 
Today, the mode of preparing medicines has mostly changed. A large amount 
of traditional remedies is produced in the big centres of traditional medicine and 
Mongolian companies using modern production methods. Ancient sutra books 
as well as more recent formula handbooks are used by traditional medicinal 
drug manufactures for the production of the preparations. In 2006 a total of 36 
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traditional medicinal drug manufactures were registered officially in Mongolia. 
They represent 16% of the total number of drug manufactures and can be found 
in public and private sectors [2]. Among the private traditional medicinal drug 
manufactures, for example, is the Training Centre of Mongolian Traditional 
Medicine Manba Datsan in Ulaanbaatar. Modern equipment allows the 
production of traditional tan and talkh preparations, pills, mixtures, extracts and 
ointments. 120 types of tan, talkh, and pills are produced using traditional and 
alternative formulas and technologies [2]. The needed plants, animal drugs or 
minerals are collected by the locals in the Mongolian countryside or are 
purchased at various markets in and outside Mongolia. Such traditional 
medicines are sold within the Republic of Mongolia by traditional medicinal drug 
wholesalers. Some of those products are even exported [1]. In 2001 public and 
private drug manufactures produced 4.8 tons of traditional medicinal drugs. In 
comparison to that, the total amount of traditional medicinal drugs produced in 
2006 increased by 60% up to 7.8 tons. This reflects the increasing importance 
of traditional medical treatment in Mongolia. In 1965 Mongolia started the 
implementation of a quality control system founding the Mongolian State Central 
Inspection Laboratory. Today, this institution and the State Inspection Agency 
are responsible for monitoring and standardizing traditional preparations with 
many ingredients to ensure their quality. Mechanisms of regulation include the 
Mongolian drug law (1998), an approved list of standardized medicinal raw 
materials as well as inspection guidelines for traditional medicinal materials and 
formulas (2003). Furthermore, validated procedures for analyses of active 
ingredients by TLC or HPLC are very important. According to the policy on 
improving the Mongolian Traditional Medicine new model guidelines of 
inspection are going to be developed similarly to the international guidelines. 
E.g., the microbiological quality is evaluated by the enumeration of total bacteria 
and fungi contamination of traditional drugs. All traditional medicinal drug 
manufactures are expected to provide medicinal raw materials for inspection by 
the State Inspection Agency Central Laboratory. Nevertheless, further 
improvement of standardization and quality inspection of traditional medicines is 
required to ensure a high quality [2]. 
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1.1.4 The Mongolian health care system 
 
Information about the Mongolian health care system can be found mainly in 
reports prepared for the WHO, such as the “Health indicators Mongolia” [3] or 
the review “Health Systems in Transition” [4]. The following passages give an 
insight into the development of the Mongolian health care system since the 
beginning of the 1990s. However, some details remain unclear due to a lack of 
information. 
 
With the economic transition after the political changes in the former Soviet 
Union the state expenditure for the social sector in Mongolia fell and the quality 
of health care decreased dramatically as the health care system could not 
maintain itself. During this transition period international aid and donor's 
assistance helped to compensate the withdrawal of Soviet financial and social 
support. The resource gap in the social system in the early 1990s was filled by 
introduction of user fees and in 1994 by the introduction of a compulsory health 
insurance. The system is now financed primarily through the state budget for 
fixed costs, while variable costs are covered by the Health Insurance Fund 
(HIF). Since 1993, there has been a series of attempts to develop a package of 
"essential" and "complementary" health care services. Now the "essential" 
package of services, which includes medical emergency and ambulance 
services, and treatment for certain diseases requiring long-term care, is 
provided free of charge, whether or not a patient is covered by health insurance. 
All other services, generally curative and diagnostic, are included in the 
"complementary" package, which is financed by the HIF [4]. According to the 
report “Health indicators Mongolia” [3] the Mongolian health care system is 
characterized by three levels of care: primary health care is provided mainly by 
family group practises in Ulaanbaatar, in aimag centres, and in soum and inter-
soum hospitals. Secondary care takes place in district general hospitals in 
Ulaanbaatar and in aimag general hospitals. Tertiary care is provided in major 
hospitals and specialized professional centres in Ulaanbaatar [3]. Unfortunately, 
it is not specified which services are exactly included in the three levels of care. 
Traditional medical clinics and supervision rooms were established in the capital 
and aimag's central hospitals according to the implementation of the Ministry of 
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Health (MoH) policy – Development of Mongolian Traditional Medical Service 
from 1991-1995. The aim was to increase the number of traditional specialists 
in the capital and in aimags’ hospital services and to facilitate the organization 
of basic traditional medical training in the capital, aimags and districts. The first 
clinical traditional wards with 50 beds and 8 supervision rooms were opened in 
the State Clinical Central Hospital in 1989. The hospital division was later 
expanded to become the Traditional Medicinal Scientific Technology 
Corporation with 120 beds in 1998. The Hepatological Clinical Centre of 
Traditional Medicine, the Traditional Medical Training Centre Manba Datsan, 
and 110 private sector hospitals were established in 1991 [2]. 51.1% of the 
traditional medical hospitals budgets are sourced from a mixture of funders. 
Since 2002 the number of traditional hospitals in Ulaanbaatar has increased up 
to 79 in 2006. An important topic is the education of traditional medical doctors 
and nurses. Since the late 1990s traditional medical doctors have been 
educated in public and private universities in Mongolia. The Department of 
Traditional Medicine was founded in 1989 by the decision of the Health 
Sciences University of Mongolia (HSUM) with 3 lectures and 24 students. In 
1993 the first traditional medical doctors graduated. The School of Traditional 
Medicine was established as one of the 7 independent institutes of HSUM in 
2000. In two other public institutions, Darkhan city's Medical college and Govi-
altai's Medical college, traditional medical doctor assistants and nurses are 
educated. Otoch Manramba Medical University was established in 1991 as the 
first private traditional medical university. In total, for the years 1991-2008, 2102 
traditional medical doctors have been graduated, and all over Mongolia 331 
traditional medical doctors are working in the public health sector [2]. 
 
1.1.5 Health situation in Mongolia 
 
Since the beginning of the 1990s an increasing prevalence of lifestyle-related 
chronic diseases has been observed and has become an important public 
health issue. The number of people suffering from cardiovascular diseases, 
cancer, injuries, and poisonings has increased, while deaths from 
communicable and respiratory diseases have declined. However, respiratory 
and gastrointestinal diseases still dominate the morbidity pattern. Infectious 
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diseases, like HIV, sexually transmitted infections (STI), tuberculosis (TB), viral 
hepatits, and zoonotic diseases, which are related primarily to risk factors, such 
as behaviour, lifestyle choices, and living conditions, are showing a tendency to 
increase. The Mongolian Steps Survey on the Prevalence of Non-
Communicable Disease Risk Factors 2006, conducted by the Ministry of Health, 
revealed that 90.6% of the surveyed population had at least one risk factor for 
developing a non-communicable disease (NCD), 20.7% had three or more risk 
factors or were at high risk. The government of Mongolia has been active in 
population health education campaigning, but health behaviours remained 
largely unchanged. Although the majority of respondents knew about the 
negative impact of alcohol on health, drinking and smoking rates are high. It 
could be argued that the high levels of alcohol consumption and smoking are 
closely related to the socioeconomic problems of the transitional period, 
including poverty and unemployment [4]. However, a survey in 2005 showed 
the prevalence of smokers to be 28%, among them 24.2% daily smokers. In 
addition, 23% of the surveyed population reported low levels of physical activity. 
The National Programme on NCD Control and Prevention for 2006-2015 aims 
to reduce risk factors, thus contributing to a reduction in NCD morbidity and 
mortality [5]. In 2008 the leading causes for outpatient morbidity were diseases 
of the respiratory system, the digestive system, the genitourinary system, and 
the circulatory system. The incidence of those diseases were in general higher 
in rural than in urban areas. The predominant causes of hospitalization in soum 
and aimag hospitals were diseases of the genitourinary and respiratory system, 
whereas the residents of Ulaanbaatar were mainly admitted because of 
diseases of the digestive and circulatory systems. Moreover, 25.6% of the 
patients with diseases in the digestive system had liver problems. 13.7% 
suffered from cholecystis. Compared to the figures of 2000, the number of 
patients with liver problems increased from 18.9% to 25.6%, whereas the 
number of patients with cholecystis decreased from 14.6% to 13.7% in 2008 [3]. 
As medicinal plants are often employed for the treatment of diseases related to 
the digestive system, scientific research on the used remedies and traditional 
preparations is required. This was one of the reasons for the starting of the 
Austrian-Mongolian research-cooperation on traditional Mongolian medicinal 
plants. 
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1.2 Liver and bile flow 
 
The liver plays an important role in the metabolism and has a number of 
functions in the body, among them detoxification, protein-biosynthesis, and 
glycogen storage. It is the largest glandular organ in the human body and 
produces the bile which aids in the digestion via emulsification of lipids. The 
organ is located on the right side of the abdominal cavity beneath the 
diaphragm, and it is divided into two lobes of unequal size. On the lower, 
concave, side of the liver (porta hepatis) two important blood vessels are 
entering: the hepatic artery (arteria hepatica) and the portal vein (vena porta). 
The venous blood, brought via the portal vein from the stomach, small intestine, 
and related organs, contains digested nutrients and covers about 75% of the 
liver's blood supply whereas the hepatic artery blood, enriched in oxygen, 
contributes to the blood supply only to 25%. Furthermore the bile ducts (ductus 
hepatici) are leaving the liver via the porta hepatis. The liver tissue is composed 
of lobules of 1-2 mm size, which are separated by weak connective tissue. Each 
lobule consists of hepatocytes, which possess a wide spectrum of different 
enzymes, and carry out most of the liver functions. The hepatocytes, forming 
characteristic tissue structures, are nerved by capillary vessels (sinusoids). 
Their wall is formed by two cell types, namely endothelial cells and kupffer cells. 
Kupffer cells are specialized macrophages and part of the reticuloendothelial 
system [8]. 
The bile is produced by hepatocytes and secreted into bile canalicula which 
start in the centre of the liver lobules and merge in the periphery of the lobules, 
forming the left and right hepatic ducts. The hepatic ducts merge near the porta 
hepatis and form the so called common hepatic duct (ductus hepaticus 
communis). The cystic duct (ductus cysticus) joins with the common hepatic 
duct and forms the common bile duct (ductus choledochus). Bile can either 
drain directly via the common bile duct into the duodenum or be temporarily 
stored in the gallbladder via the cystic duct [8]. 
Biliary secretion (choleresis) relies on two mechanisms. On the one hand, 
excretion of conjugated bile acids, bilirubin and organic ions leads to an osmotic 
gradient which is responsible for the passive water movement into the 
canalicula (bile salt dependent bile flow). On the other hand, an osmotic 
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gradient is developed by an active Na+-transport from hepatocytes into the 
canalicula or the excretion of other osmotically active compounds which is also 
followed by an increased water flow into the hepatic duct (bile salt independent 
bile flow). On its way through the hepatic duct the bile is modified by 
reabsorption or secretion of electrolytes, which has an impact on the additional 
flow or the reabsorption of water. The bile consists of conjugated bile acids, 
cholesterol, phospholipids (lecithin), enzymes, and anorganic ions (Na+, Cl-, 
HCO3-). The production of bile is stimulated by secretin, a peptide hormone, and 
bile acids itself [8]. Bile acids are amphipathic steroidal compounds derived 
from the enzymatic catabolism of cholesterol, which is the most important route 
to eliminate cholesterol from the body. Bile acids are conjugated at their 
terminal carboxyl group with either glycin (mainly in humans) or taurin (mainly in 
rodents). This amidation increases their amphipathic character making them 
more hydrophilic and better excretable into the bile. In the intestinal lumen 
bacterial enzymes dehydroxylate bile acids, and a part of these secondary bile 
acids is absorbed from the intestine and recirculates entero-hepatically. The 
detergent properties of bile acids aid in the solubilisation of cholesterol in bile 
and of dietary fats and cholesterol in intestinal fluid, a prerequisite for their 
intestinal absorption [9]. The complex anatomical structure of the liver and the 
biliary tree makes clear that liver and biliary tract diseases and their clinical 
manifestations can not be classified easily. Furthermore, it has to be considered 
that its unique dual blood supply makes the liver an intermediate filter of most of 
the venous drainage of the abdominal viscera. This often leads to secondary 
hepatic involvement in a number of extrahepatic diseases and makes the liver a 
relatively common site of solid tumor metastases [10]. 
A reduced function of the liver and the gallbladder is generally associated with 
an impairment of the bile flow. Plant extracts, exhibiting bile-flow-stimulating 
effects, may resolve disturbances in the hepato-biliary system caused by a 
reduced bile secretion (cholestasis). Phytotherapy, as applied in Western 
countries, suggests a variety of plants to cure disorders of stomach, liver and 
the biliary system. Discomfort in the stomach, bloating, lack of appetite, nausea 
and mild diarrhoea or constipation are improved by the intake of choleretic 
compounds such as artichoke leaf extract which stimulates bile secretion and 
shows hepatoprotective effects in animal models [11]. 
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Fig. 1 Influence of aqueous extracts from selected Mongolian medicinal 
plants on bile flow tested in two different concentrations in the model of 
the isolated perfused rat liver. (chapter 2.4.1 p. 27) D. versicolor is 
indicated by the red arrow. 
In cooperation between the Department of Pharmacognosy, University of 
Vienna, the Health Sciences University of Mongolia, and the Institute of 
Pathophysiology, Medical University of Vienna about 20 plants were selected 
which are most frequently used in the therapy of liver disorders according to 
TMM. Methanolic and aqueous extracts of these plants were screened for their 
effect on the bile flow in the model of the isolated perfused rat liver (Fig. 1) [1]. 
Such experiments are not only suitable to detect choleretic effects but provide 
also a possibility for investigations of metabolites secreted into the bile. Thus, 
extracts from the Mongolian medicinal plant Saussurea amara were identified 
as potent choleretic agents [12]. Furthermore, an aqueous extract of D. 
versicolor showed a dose dependent effect on the bile flow in the tested 
concentrations (Fig.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Due to these results D. versicolor was chosen for intensive phytochemical 
investigation and further biological testing presented within this PhD thesis. 
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1.3 Dianthus versicolor FISCH.  
 
Dianthus versicolor FISCH. belongs to the plant family of the Caryophyllaceae. It 
is distributed mainly in Asia, e.g. Siberia, Kazakhstan, Mongolia (except the 
Southern provinces), and China, but also in Eastern Europe, e.g. Ukraine [13, 
14]. 
The plant is a perennial herb with a height of 20-50 cm and branched stems. 
The sessile lineal-lanceolate leaves in opposite position are 13-18 mm long and 
3-7 mm wide. Flowers can stand solitary or in groups of two or three. The calyx 
is a tube of 13-18 mm length and 3-5 mm width. The petals are 20-25 mm long 
and of purple colour [15]. On the inner side of each petal a wing-like appendage 
is visible, and five brownish nectaries are located at the base of the stamens. 
The plant grows on rocky ground, pebbles or in the steppe. 
 
 
 
Until now literature on anatomical investigations of D. versicolor is not available. 
First microscopic analyses show anatomical structures which are similar to 
Dianthus superbus. On the leaf numerous short unicellular trichomes with 
Fig. 2 Dianthus versicolor; photo: Christa Kletter, Dept. of Pharmacognosy, Vienna 
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Fig. 3 Microscopic investigation of a D. versicolor leaf; the surface view (x 400) shows short 
unicellular hairs; photo: Christa Kletter, Dept. of Pharmacognosy, Vienna 
thickened cell wall and warty cuticle are visible. The stomata appear diacytic, 
and epidermis cells show bead-like thickenings. Oxalate druses appear in leaf, 
stem and sepals. On the sepals and petals uni- to multicellular hairs are found. 
The epidermis of the ovary is partly turned into a sclerenchyma with papillose 
style [16]. To confirm these first results detailed analyses concerning the 
distribution of microscopic characters in different tissues of the plant are 
required. Therefore further investigations on a greater number of herbarium 
specimens are in progress [17]. 
 
 
In traditional medicine the aerial parts (flowers, stems, and leaves) are used. 
Data about the chemical composition of this plant are scarce. Boguslavskaya et 
al. described two flavonoid-C-glycosides, namely chrysoeriol-6-C-syn-α-D-
glucopyranoside and chrysoeriol-6-C-anti-α-D-glucopyranoside [18]. Ma et al. 
identified seven new and nine known triterpenoid saponins in D. versicolor [19]. 
Some of those compounds showed inhibitory effects on various cell-lines. 
Furthermore, alkaloids, cumarines, and ascorbic acid are said to be contained 
in the aerial parts of this plant [15]. D. versicolor (in Mongolian alag bashir) is 
described as beneficial in chronic pain. It influences the blood pressure and is 
used to treat cardiovascular diseases by traditional physicians. Due to its 
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property to increase the contractility of the uterus, D. versicolor is used against 
bleeding after birth and against strong bleeding during menstruation in 
Mongolian, Tibetan, and Russian medicine. It is furthermore known to be 
beneficial in pneumonia, typhoid fever, and poisoning. Its actions include 
diuretic and anti-inflammatory effects, and, despite its staunching properties, it 
may cause bleeding when overdosed. Beside these indications, D. versicolor is 
also used against liver diseases in various prescriptions by traditional health 
institutions [20]. For example, prescription number 10 according to the 
traditional Mongolian physician Dr. Natsagdorj is used for the treatment of liver 
ailments. It contains 5 ingredients, among them 25% D. versicolor. Another 
prescription, number 5, consists of 25 ingredients, but contains only 3% D. 
versicolor [20]. As described in chapter 1.1.2, p. 5-6, the choice of the proper 
prescription for the treatment of a certain disease depends on the exact 
diagnosis. According to the traditional Mongolian physician Dr. Natsagdorj D. 
versicolor is also used as a substitute of D. superbus L. (in Mongolian 
Javhaalag bashir). This fact is in accordance with literature [15], which attributes 
similar qualities to both plants, D. versicolor and D. superbus. According to the 
“Report of market research on Mongolian traditional medicinal drugs” prepared 
in September 2007 for the WHO, D. versicolor ranks among the 45 most 
common domestic herbal drugs traded in Mongolia. With an average price of 
about € 3,- per kilogram on the local markets, it belongs to one of the most 
expensive domestic drugs in Mongolia [2]. 
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1.4 Aim of the thesis and overview of publications 
 
As traditional Mongolian medicine has become more important since the last 
two decades, scientific research is necessary to prove the efficacy of the 
therapeutic methods and the medicinal plants applied to patients. 
Phytochemical data about D. versicolor are scarce, as mentioned in chapter 1.3 
p. 14-16. Therefore, the aim of this thesis was first the bioassay-guided 
fractionation of a D. versicolor aqueous extract, applying chromatographic 
techniques. In the next step the fractions, which showed a positive impact on 
the bile-flow in the model of the isolated perfused rat liver, should be 
characterized phytochemically employing TLC, HPLC-DAD and HPLC-MSn. 
This approach should lead to the isolation, identification, and structure 
elucidation of active compounds by multidimensional matching employing LC-
MSn, GC-MS, UV-, and NMR-spectroscopy. Publication 1 [21], pp. 127-133, 
comprises the investigations of D. versicolor extracts and fractions in the model 
of the isolated perfused rat liver. In publication 2 [22], pp. 30-85, the isolation 
and structure elucidation of flavonoid-glycosides, which are supposed to 
contribute to the choleretic effect, is described in detail. Furthermore, as a basis 
for quality control, appropriate analytical methods including applications for the 
quantification of the flavonoid-glycosides should be established. This was 
realized by the development of an analytical HPLC-DAD method using 
isovitexin-7-O-glucoside as external standard and is described in publication 3 
[23], pp. 87-112. Additionally, in publication 4 [24], pp. 113-125, the 
quantification of flavonoids applying a validated HPLC-DAD method especially 
developed for the separation of very polar compounds is compared to 
quantification by UV-spectrophotometry. 
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2 Material and methods 
 
This chapter provides a short overview of the methods applied in this thesis. 
Further information is given in the experimental sections of the four publications 
included in section 3, pp. 29-133. 
 
2.1 Plant material 
 
The aerial parts of D. versicolor were collected in the years 2003-2005 in 
different regions in Mongolia (Fig. 4). The plant material was identified by E. 
Ganbold, State University of Mongolia, Ulaanbaatar. Voucher specimens are 
deposited at the Institute of Botany, State University of Mongolia, Ulaanbaatar, 
Mongolia and the Department of Pharmacognosy, University of Vienna, Vienna, 
Austria (Table 1, p. 19). 
 
 
 
 
Due to the fact, that each experiment required the sacrifice of an animal, 
biological investigations were carried out exclusively on sample a. Based on 
these results a bioassay-guided fractionation was conducted with the aim of the 
a d, e 
b 
c 
Fig. 4 Map of Mongolia indicating the collections sites of different D.versicolor samples; 
assignments correspond to the samples listed in Table 1, p. 19 
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isolation of new compounds. All five samples were compared phytochemically 
by TLC and HPLC-analysis showing qualitative similarity but quantitative 
differences regarding the flavonoid pattern. 
 
 
 
 
2.2 Extraction, fractionation and isolation  
 
2.2.1 Preparation of the aqueous extract (OWE) 
 
According to the traditional way of intake (chapter 1.1.3, p 6) a special aqueous 
extract, named "Original Water Extract" (OWE) was prepared. 100 g of the dried 
aerial parts of D. versicolor (sample a) were extracted with 2.5 L of water, 
adjusted to pH 2 with trifluoroacetic acid (TFA), for 1 h at 40°C by shaking 
gently, in order to simulate the acid pH of the stomach. After the extraction 
process, the highly volatile TFA was removed under reduced pressure at a 
temperature of 45°C and the resulting solution was freeze dried yielding 21.9 g 
of OWE (DER 1:0.213). This OWE served for the biological investigations in the 
isolated perfused rat liver (chapter 2.4.1, p. 27; publication 1 [21], chapter 3.3, 
pp. 127-133) as well as for the fractionation and isolation of compounds (Fig. 7, 
p 23, publication 2, chapter 3.1. pp. 30-85). A scheme of the extraction and 
fractionation by SPE is given in Fig. 5. 
Sample Collection number 
Collection site 
and year 
Herbarium number 
(Dept. of Pharmacognosy) 
Herbarium number 
(Inst. of Botany) 
a 53/04/mon  Khubsgul August 2004  424 
b 52/04/mon Bulgan August 2004 03/04/mon/H  
c 02/05/mon Khentii August 2005  H 20050805 
d 05/03/mon Selenge July 2003 14/03/mon/H  
e 06/03/mon Selenge July 2003 14/03/mon/H  
Table 1 Samples a-e of D. versicolor collected in the years 2003-2005 in Mongolia (see Fig. 4, p. 18) 
 20
 
 
 
 
2.2.2 Solid phase extraction (SPE) 
 
Solid phase extraction was used for the purification and fractionation of the 
OWE. A total amount of 2.4 g of OWE was applied on C 18 cartridges and 
eluted with different ratios of MeOH/H2O mixtures. The four resulting fractions 
were either lyophilized or dried under reduced pressure at a maximum 
temperature of 45°C. The method is described in detail in the experimental 
sections of publications 1 [21] and 2 [22] (chapter 3.3, pp. 127-133, chapter 3.1. 
pp. 30-85) and the fractionation scheme is given in Fig. 5, chapter 2.2.1, p 20. 
 
2.2.3 Centrifugal partition chromatography (CPC) 
 
Centrifugal partition chromatography is a chromatographic technique based on 
liquid-liquid partition between stationary and mobile phase. In contrast to 
common column chromatography this technique allows the fast separation of 
compounds without any loss of substance due to adsorptive effects of 
Drug 
(pulverised) 
OWE 
SPE 
H2O 
10% MeOH 
40% MeOH 
100% MeOH 
Extraction 
with 
water (pH2) 
40°C, 1h 
CPC 
Fractions
1-19 
Residue 
Fig. 5 Extraction-scheme of the aerial parts from D. versiolor and fractionation of the OWE by 
SPE and CPC; the purple colour indicates testing in the isolated perfused rat liver (chapter 
2.4.1, p. 27; publication 1, chapter 3.3, pp. 127-133)
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Fig. 6 Scheme of fractionation of the OWE (2.2.1, p 19) by CC on Polyamide and 
Sephadex LH-20.  
compounds to the stationary phase. In this study CPC was used for further 
fractionation of 80 mg of the SPE derived 40% MeOH subfraction. The applied 
method is described in detail in the experimental section of publication 2 [22] 
(chapter 3.1. pp. 30-85) the fractionation scheme is given in Fig. 5 (chapter 
2.2.1 p. 20). 
 
2.2.4 Column chromatography (CC) 
 
Column chromatography was employed for fractionation of the OWE using 
Polyamide [25]. For further fractionation of the resulting subfractions Sephadex 
LH-20 was used as stationary phase and different ratios of MeOH/H2O mixtures 
served as mobile phase. Similar fractions were unified after TLC analysis 
(chapter 2.3.1, p. 24 and chapter 3.4.1 pp. 134-137). The method is described 
in detail in the experimental section of publication 2 [22] (chapter 3.1. pp. 30-85). 
An overview of the different CC-systems and the fractionation is given in Fig. 6. 
 
 
 
 
 
 
OWE
CC 
Polyamide 
I 
(35-42) 
II 
(50-55) 
III 
62-65 
IV 
69-72 
V 
73-81 
VI 
137-153 
20% 
MeOH 
40% 
MeOH
45% 
MeOH
50% 
MeOH
85-95% 
MeOH 
35% 
MeOH 
CC I 
Sephadex 
CC II 
Sephadex 
CC III 
Sephadex 
SF 
1-6 
SF 
1-6 
SF 
1-9 
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2.2.5 Semipreparative high performance liquid chromatography 
(HPLC) 
 
Semipreparative HPLC was employed for the isolation of the compounds 1-7 
(Fig. 31, p. 152) from various fractions derived either by CPC or CC (chapter 
2.2.3 p. 20 and 2.2.4, p. 21). The method is described in detail in the 
experimental section of publication 2 [22] (chapter 3.1. pp. 30-85). In brief, 
separations were carried out applying a low pressure gradient using doubly 
distilled water (A) adjusted to pH 2.8 with TFA and MeCN (B) at a flow rate of 
1.0 mL/min. A 5µm Thermo Aquasil® C18 column (250 x 4.6 mm) served as 
stationary phase. Aqueous and aqueous/methanolic solutions (up to 40% 
MeOH) at a concentration of 2-5% served as sample solutions. As a 
consequence of the high structural similarity of the compounds in some cases 
baseline separation could not be achieved but with an injection volume of 10 µl 
the resolution was satisfying. The following scheme (Fig. 7) comprises the 
various procedures resulting in the isolation of nine flavonoid glycosides.  
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Fig. 7 Overview of the scheme of fractionation of the OWE (2.2.1, p. 19) and 
the isolation of compounds 1-7 (Fig. 31, p. 152). Green: starting material, 
red: fractions for the isolation of compounds, blue: isolated compounds 
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2.3 Analytical methods 
2.3.1 Thin layer chromatography (TLC) 
 
TLC was used for analytical purposes to get a quick overview about the 
flavonoids in the OWEs of different D. versicolor samples. It served also for a 
rapid comparison of CPC or CC derived fractions, and based on these analyses 
similar fractions were unified. Furthermore, this technique was applied for the 
identification of free sugars contained in the samples and for the identification of 
monosaccharides after acid hydrolysis of the isolated flavonoid-glycosides in 
comparison with reference substances. Silica gel coated aluminium sheets 
served as stationary phase for all analyses whereas different solvent mixtures 
were used as mobile phase. System 1 was suitable for the separation of 
flavonoid glycosides whereas system 2 was used for flavonoid aglycones. 
System 3 served for the separation of sugars. Flavonoids became visible after 
spraying with a solution of natural product reagent followed by PEG 400 under 
UV 366nm. For detection of sugars diphenylamine-aniline reagent was used. 
Zones became visible under daylight after heating the plate at 105-110°C for 10 
min. 
The different TLC-systems are summarized in table 3, the method is described 
in detail in publications 1 [21] and 2 [22] (chapter 3.3, pp. 127-133 and chapter 
3.1. p. 30-85). 
 
System 1 2 3 
Stationary phase  Silica gel  
Mobile phase 
EtOAc/HCOOH/ 
CH3COOH/H2O 
(100/11/11/26) 
CH2Cl2/cyclohexane/ 
HCOOH/ethylformiate 
(35/30/5/30) 
CH2Cl2/CH3COOHconc/
MeOH/H2O 
(60/32/12/8) 
Sample volume 5-10µl 5-10µl 5-10µl 
Detection 
Natural product 
reagent/PEG 400 
Natural product 
reagent/PEG 400 
Diphenylamine-aniline 
reagent 
 
 
 
 
 
Table 2 TLC systems 1-3 used for the separation of flavonoids and sugars 
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2.3.2 High performance liquid chromatography (HPLC) 
 
HPLC was used for analytical as well as for semipreparative purposes (chapter 
2.2.5 p. 22). Various stationary and mobile phases were tested in order to find 
the best system for the separation of the flavonoids contained in D. versicolor 
samples. Slightly different methods were developed for the quantification of the 
flavonoids by HPLC-DAD and HPLC-MSn-analysis. The methods used for 
analytical purpose required changes in the dimensions of the column, the flow 
rate, the linear gradient, and the column oven temperature. The method 
development is described in detail in chapter 3.4.2 pp. 138-147. Further details 
about the analytical HPLC methods can be found in the experimental sections 
of publications 1, 2, 3, and 4 [21, 22, 23, 24] (section 3, pp. 29-133). 
 
2.3.3 Gas chromatography-mass spectrometry (GC-MS) 
 
GC-MS was used for the identification of the sugar part of the isolated 
flavonoid-glycosides including the determination of the absolute configuration of 
the monosaccharides. These analyses demanded a special sample preparation, 
which is described in detail in the experimental section of publication 2 [22] 
(chapter 3.1. pp. 30-85) together with the exact instrument parameters of the 
GC-MS analyses. In case of the disaccharides the linkage between the two 
sugar moieties was of interest. In addition to NMR experiments, a method 
described by de Bettignies-Dutz et al. [26] which was previously applied 
successfully on saponins, was used for this purpose. In brief, the isolated 
flavonoid glycoside was permethylated, followed by acid hydrolysis with Kiliani 
reagent (1 mL HClconc/3.5 mL CH3COOH/5.5mL H2O). After liquid-liquid partition 
(EtOAc/H2O), the aqueous layer was evaporated to dryness and derivatized 
with N-methyl-N-trimethylsilyl-trifluoroacetamide prior to GC-MS analysis. 
According to de Bettignies-Dutz [27] the sugars show different fragment ions 
depending on the substitution of OH-groups either with CH3-residues or 
trimethylsilyl-residues (TMS). Therefore, different linkages can be distinguished 
in comparison to reference substances. Quercetin-3-O-rutinoside (rutoside) 
served as reference for rhamnosyl-1→6-glucoside. The results of these 
analyses are compiled in chapter 3.4.3, pp. 147-150. 
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2.3.4 UV-spectrophotometry (UV) 
 
UV-spectrophotometry was applied successfully for the determination of the 
total flavonoid content in the crude drug as well as in the OWE of Dianthus 
versicolor. Based on the monograph Passiflorae herba from the European 
Pharmacopoeia, the method was slightly modified and is described in detail in 
publications 1 [21] and 4 [24] (chapter 3.3, pp. 127-133 and chapter 3.2. pp. 
113-125). Furthermore, UV-spectroscopy was used for the identification of 
compounds 4a/4b and 5 (Fig. 31, p. 152) via the application of shift reagents 
(AlCl3/HCl and NaOMe) [28] in addition to NMR experiments as described in 
publication 2 [22] (chapter 3.1. p. 30-85). 
 
2.3.5 Mass-spectrometry (MS) 
 
Mass-spectrometry is one of the most important analytical methods for structure 
elucidation. Depending on the mode of ionisation and on the detection unit of a 
mass spectrometer comprehensive information about a chemical structure can 
be obtained. High resolution mass-spectrometry (e.g. ESI-TOF) allows the 
determination of the exact molecular mass of a compound whereas the 
fragmentation pattern obtained by MSn experiments (e.g. ESI-IT, ESI-QQQ) 
provides detailed information about certain structural elements of the molecule. 
In this thesis MS was used in combination with HPLC and GC. LC-MSn  
analyses were performed on an HPLC-ESI-IT system in the negative mode. To 
obtain high resolution masses an HPLC-coupled MicrOTOF-Q mass 
spectrometer with ESI ion source was used in the negative mode. Detailed 
information about the applied methods can be found in publication 2 [22] 
(chapter 3.1. pp. 30-85). GC-MS analyses were employed for the identification 
of sugar moieties in the flavonoid glycosides as described in chapter 2.3.3, p. 
25 and in the experimental section of publication 2 [22] (chapter 3.1. p. 30-85). 
 
2.3.6 Nuclear magnetic resonance spectroscopy (NMR) 
 
NMR is certainly the most important spectroscopic technique applied in 
structure elucidation. It facilitates the investigation of the chemical environment 
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of certain nuclei – in organic chemistry usually 1H and 13C nuclei– and their 
interactions with vicinal atoms. Besides the 1D techniques 1H and 13C 
spectroscopy a number of 2D experiments provides the possibility of 
establishing the chemical structure of an investigated compound. In this study 
1H, dqfCOSY (double quantum filtered correlation spectroscopy, H, H 
correlation), HSQC (heteronuclear single quantum coherence, vicinal H, C 
correlations), HSQC-TOCSY (initial HSQC pulse followed by a TOCSY – total 
correlation spectroscopy sequence) and HMBC (heteronuclear multiple bond 
cohrerence, H, C long range coupling via 2-4 bonds) experiments were 
conducted. NMR-experiments were carried out in cooperation with Prof. Armin 
Presser, Institute of Pharmaceutical Sciences, University of Graz. The method 
is described in detail in the experimental section of publication 2 [22] (chapter 
3.1., p. 30-85). 
 
2.4 Biological methods 
 
2.4.1 Isolated perfused rat liver 
 
The isolated perfused rat liver was chosen as an ex-vivo model for the detection 
of choleretic effects in the aqueous extract and fractions prepared from the 
aerial parts of D. versicolor. These investigations were carried out in 
cooperation with Prof. Theresia Thalhammer, Institute for Pathophysiology, 
Medical University of Vienna. The method is described in detail in publication 1 
[21] (chapter 3.3, p. 127-133) 
2.4.2 Isolated organ preparations 
 
As mentioned in the introduction (chapter 1.3. p. 14) according to Ligaa [15] D. 
versicolor is used as a uterus constringing agent against strong bleeding after 
birth and during menstruation. Furthermore, D. versicolor is said to have an 
influence on the blood pressure and to be used for the treatment of 
cardiovascular diseases. In order to investigate the effects of the OWE on the 
uterus, the heart, arteria pulmonalis, terminal ileum, and the aorta, tests on 
guinea-pig derived isolated organs were conducted. Those were performed by 
 28
Birgit Weisz-Pecher [29] at the Department of Pharmacology and Toxicology, 
University of Vienna in cooperation with Prof. Lemmens-Gruber. The OWE was 
tested in three different concentrations (1, 3, and 9 mg/mL) and evaluated 
regarding the force of contraction. For further investigation of the mechanism 
behind, smooth muscle cells were isolated from the arteria pulmonalis and the 
uterus. In order to investigate a possible influence on the intracellular Ca 2+ 
concentration, the cells were treated with 0.3, 3, and 9 mg/mL of the aqueous 
extract solution. Details regarding these investigations can be found in the 
diploma thesis of Birgit Weisz-Pecher [29]. 
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3 Results 
 
This chapter is divided into four sections describing the results of the thesis. At 
the beginning of each section a brief overview of the publications, either 
submitted or published, and a report on what has been achieved by Astrid 
Obmann is given. 
 
3.1 Preparative section 
 
The isolation and structure elucidation of nine flavonoid-glycosides from the 
OWE of Dianthus versicolor is described in the following manuscript 
“Flavonoid C- and O-glycosides from the Mongolian Medicinal Plant 
Dianthus versicolor FISCH.“, which is in preparation to be submitted to the 
journal Chemical & Pharmaceutical Bulletin [22]. The isolation and structure 
elucidation of compounds 1-6 (Fig. 31, p. 152) was carried out by Astrid 
Obmann at the Department of Pharmacognosy. Compound 7 (Fig. 31, p. 152) 
was isolated by Tina Radovic [25] under the supervision of Astrid Obmann who 
identified the compound. Compound 8 was isolated by Zita Swoboda [30] under 
the supervision of Astrid Obmann who identified the compound. HR-ESI-MS 
was measured at the Department of Nutritional Sciences, University of Vienna. 
NMR spectra were recorded at the Institute of Pharmaceutical Sciences, 
University of Graz. 
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Abstract 
Eighteen flavonoids were identified in an aqueous extract of the aerial parts of Dianthus 
versicolor, a plant used in traditional Mongolian medicine against liver diseases. The 
flavonoid C- and O-glycosides isoorientin-7-O-rutinoside, isoorientin-7-O-rhamnosyl-
galactoside, isovitexin-7-O-rutinoside, isovitexin-7-O-rhamnosyl-galactoside, 
isoscoparin-7-O-rutinoside, isoscoparin-7-O-rhamnosyl-galactoside, isoscoparin-7-O-
galactoside, and isoorientin-7-O-galactoside were isolated and structurally elucidated. 
Their structures were established on the basis of extensive spectroscopic techniques 
including LC-UV-DAD, LC-MSn, LC-HRMS, 1D and 2D NMR, and by GC-MS 
analysis after hydrolysis. Furthermore, isovitexin-7-O-glucoside (saponarin), isovitexin-
2''-O-rhamnoside, apigenin-6-glucoside (isovitexin), luteolin-7-O-glucoside, apigenin-
7-O-glucoside, as well as the aglycones luteolin, apigenin, chrysoeriol, diosmetin, and 
acacetin were identified by TLC and LC-DAD-MSn comparison to reference substances 
or literature data. All compounds are reported for D. versicolor for the first time. Most 
of them have not been described for the genus Dianthus until now. 
 
Keywords: Dianthus versicolor, Caryophyllaceae, ethnopharmacognosy, traditional 
Mongolian medicine, isolation, structure elucidation, flavonoids 
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1. Introduction 
The genus Dianthus L. (Caryophyllaceae) includes more than 300 species distributed 
mainly in Eurasia (Angiosperm Phylogeny Website, 2010). It is a summer flowering 
shrub and contains many narrow endemics, especially in Europe (Valente et al., 2010). 
Flavonoids seem to be a relevant class of compounds for this genus, as shown by a 
number of publications from the late seventies up to now. However, among the 300 
species only 14 are referred to in literature. 34 flavonoids have been described so far - a 
summary of those compounds, the corresponding species and references are given in 
Table 1. 
In our investigations we focus on Dianthus versicolor FISCH.1, one of the five Dianthus 
species growing in Mongolia according to Grubov (2001). D. versicolor is a purple to 
pink flowering herb distributed all over the country except the Southern provinces close 
to the Chinese border (Grubov, 2001; Boldsaikhan, 2004). The aerial parts are used in 
traditional Mongolian medicine for various purposes. D. versicolor is described as 
beneficial in chronic pain (Boldsaikhan, 2004), it influences uterus motility 
(Boldsaikhan, 2004), and is applied to treat liver diseases (Kletter et al., 2008). The 
chemical composition of D. versicolor is not well studied; publications on 
phytochemistry and biological activity are scarce. Two Russian publications from the 
early eighties report on flavonoids but lack any NMR data (Boguslavskaya et al., 1983a; 
Boguslavskaya et al., 1983b). A paper published just recently by Ma et al. (2009) 
presents seven new and nine known triterpenoid saponins isolated from an ethanolic-
aqueous (80%) extract of the aerial parts. For nine of these compounds cytotoxic 
activities against various cell lines were shown (Ma et al., 2009). 
With regard to the use of D. versicolor in traditional Mongolian medicine as a cure 
against liver impairment, we performed experiments in the isolated perfused rat liver in 
                                                 
1 The denomination of the species bases on Grubov (2001) 
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a recently published study (Obmann et al., 2010). For the aqueous extract and an 
enriched fraction, bile flow enhancing properties were recorded without any signs of 
acute hepatotoxicity. The aqueous extract as well as the enriched fraction contained 
mainly flavonoids, which seem to contribute to the favourable effect of D. versicolor on 
the gastrointestinal tract (Obmann et al., 2010). In the present paper we report on the 
isolation and structural characterisation of 18 flavonoids from the aerial parts of D. 
versicolor, seven of them are new to the best of our knowledge.  
 
2. Results and Discussion 
The separation of compounds 1-16 was achieved by HPLC. The differences in the 
polarity of the constituents required the development of three different gradient systems 
which provided the separation within acceptable retention times (see Fig. 1A-C). 
Compounds 1, 2, 3a, 3b, 4a, 4b, 5, and 6 were isolated and structurally elucidated 
applying HR-MS, UV, and NMR. Their UV-spectra, which were recorded online during 
analytical HPLC (Fig. 1A), are typical for flavonoids (Markham, 1982). Structural 
differences are apparent at position C-3’ (Ring B) of the aglycones: apigenin (3’-H) is 
the basic structure for 3a and 3b, whereas for 1, 2, and 6 the aglycone is luteolin (3’-
OH), and for 4a, 4b, and 5 it is chrysoeriol (3’-OCH3) (see Fig. 2). All compounds are 
C-glycosides linked in position C-6 of the aglycone. This was confirmed by NMR 
analysis: the recorded NMR data are typical for a C-glucoside (Leitão and Delle 
Monache, 1998). In addition, the HMBC spectra showed a clear correlation between H-
1’’ and C-6. The combined informations indicated that the basic C-monoglycosides are 
isovitexin, isoorientin, and isoscoparin. This was confirmed by HPLC-UV analysis of 
the EtOAc fraction after acid hydrolysis in comparison with reference substances. 
Moreover, all compounds showed characteristic fragmentation patterns in the LC-MSn 
analysis: MS2 experiments of compounds 5 and 6 revealed a neutral loss of 162 Da 
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suggesting the occurrence of an O-linked hexose (Qimin et al., 1991). For compounds 1, 
2, 3a, 3b, 4a, and 4b a neutral loss of 308 Da was found, suggesting an O-linked 
disaccharide moiety consisting of hexose (neutral loss: 162 Da) and deoxyhexose 
(neutral loss: 146 Da) (Qimin et al., 1991). In MS3 experiments on the de-O-
glycosylated fragment ions of each compound, typical losses of 120 and 90 Da, which is 
due to the cross-ring cleavage of the C-glycosylic moiety (Qimin et al., 1991), were 
observed. 2D NMR experiments indicated an O-linkage of the hydrolysable moiety – 
either a monosaccharide or a disaccharide – in position 7 of the aglycone. Acid 
hydrolysis and subsequent GC-MS analysis revealed the occurrence of the hexoses 
glucose or galactose. The deoxyhexose was identified as rhamnose. Correlations of H-
1’’’ to C-7 and H-1’’’’ to C-6’’’ in the HMBC spectra suggested a rhamnosyl-
(1→6)glucose (compounds 1, 3a, 4a) and a rhamnosyl-(1→6)galactose unit (2, 3b, 4b) 
in position 7 of the aglycone (Fig. 3). Compounds 5 and 6 were determined as 7-O-
galactosides. NMR data indicated -orientation for C-1 of all glucoses and galactoses, 
and α-orientation for C-1 of the rhamnose-moieties. The absolute configuration of the 
sugars was determined by the preparation of chiral derivatives as described by Reznicek 
et al. (1993). After acid hydrolysis of the glycosides, the monosaccharides were 
subjected to reaction with (R)-(-)-2-BuOH and subsequent derivatization with N-
methyl-N-trimethylsilyl-trifluoracetamide (MSTFA). The diastereomeric 
butylglycosides were analyzed by GC-MS revealing D-configuration for glucose and 
galactose, and L-configuration for rhamnose. 
Compound 1 was obtained as a yellow amorphous powder, [α]20D -48. HR-ESIMS 
experiments showed an [M-H]¯ ion at m/z 755.1993 (calculated for C33H39O20 
755.2040). HSQC experiments suggested the presence of two anomeric protons (δ 5.43, 
d, H-1’’’, and δ 5.58, s br, H-1’’’’) with corresponding 13C-resonances at δ 103.5 (C 
1’’’) and δ 102.4 (C 1’’’’). Another signal at δ 5.78, d, with the chemical shift value of 
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C 1’’ at δ 74.8 indicated the presence of an additional C-glycosidic unit. Furthermore, 
12 CH-signals, 2 CH2-signals and 1 CH3-signal were identified (Table 2), demonstrating 
the existance of two hexoses and one deoxyhexose. The chemical shifts of the 
carbohydrate units were in perfect accordance with the data reported for glycosides with 
similar glycosylation pattern (Li et al., 2005; Rayyan et al., 2005) and suggested glucose 
for the two hexoses and rhamnose for the deoxyhexose. The combined information from 
acid hydrolysis, 1D and 2D NMR experiments, and mass spectrometry of 1 revealed the 
flavonoid-C-monoglycoside isoorientin (luteolin-6-glucoside) as basic skeleton. This 
was confirmed by HPLC retention time and UV spectra in comparison to the authentic 
reference. Characterization of the O-linked disaccharide unit was performed by 
derivatization and subsequent GC-MS analysis, proving glucose and rhamnose as 
constituents. Therefore the structure of 1 is confirmed as a luteolin-6-C-β-D-
glucopyranosyl-7-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (isoorientin-7-
O-rutinoside). This compound has been described before from Triticum aestivum (Julian 
et al., 1971), however, the respective paper lacks any MS and NMR data. For D. 
versicolor this compound is described for the first time. 
Compound 2 yielded a slightly yellow amorphous powder, [α]20D -33. HR-ESIMS 
experiments showed an [M-H]¯ ion at m/z 755.1991 (calculated for C33H39O20 
755.2040). NMR resonances were similar to compound 1 except for the chemical shifts 
of spin system H-1’’’ (Table 2). GC-MS analysis suggested the presence of a galactose, 
which was supported by NMR analysis. Furthermore, 2D NMR experiments proved the 
linkage of the side chain in position 7 of the aglycone. These findings confirm the 
structure of 2 as a luteolin-6-C-β-D-glucopyranosyl-7-O-α-L-rhamnopyranosyl-(1→6)-
β-D-galactopyranoside (isoorientin-7-O-rhamnosyl-galactoside), which is a new 
compound. 
 36
Compounds 3a and 3b were obtained as a mixture (yellowish amorphous powder) in a 
ratio of 2:1. HR-ESIMS experiments yielded isobaric [M-H]¯ ions at m/z 739.1993 
(calculated for C33H39O19 739.2091). NMR structure analyses suggested a C-6-
glucosylated apigenin as basic structure (Ohkawa et al, 1998) (Table 2). In addition, the 
carbohydrate chains showed a high analogy to those found for 1 and 2. This led us to 
the hypothesis, that compound 3a represents a 7-O attached rhamnosyl-glucoside, 
whereas 3b is a rhamnosyl-galactoside. This assumption was confirmed by GC-MS 
sugar analyses, which revealed the existence of the monosaccharides glucose, galactose, 
and rhamnose. In conclusion, the structure of 3a was established as apigenin-6-C-β-D-
glucopyranosyl-7-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (isovitexin-7-
O-rutinoside) and the structure of 3b as apigenin-6-C-β-D-glucopyranosyl-7-O-α-L-
rhamnopyranosyl-(1→6)-β-D-galactopyranoside (isovitexin-7-O-rhamnosyl-galacto-
side). Compound 3a has been isolated before from Hordeum vulgare var. nudum leaves 
(Ohkawa et al., 1998), but is new for D. versicolor. Compound 3b is a new compound. 
Compounds 4a and 4b were obtained as a mixture (yellow amorphous powder) in a 
ratio of 1.5:1. HR-ESIMS showed for both an [M-H]¯ ion at m/z 769.2171 (calculated 
for C34H41O20 769.2197). NMR data suggested a chrysoeriol-6-C-glucoside as basic 
structure due to the following findings: In comparison to the previously described NMR 
experiments, the data of 4a and 4b showed a remarkable signal at δH 3.88 and δH 3.86, 
respectively, and at δC 56.3 (Table 2), which was identified as OCH3 group in position 
3’. The NMR resonances of the sugar chains in 4a and 4b were almost identical to that 
obtained from 3a and 3b (Table 2). Acid hydrolysis of the mixture led to the 
chrysoeriol-6-C-glucoside skeleton (isoscoparin), which was published by 
Boguslavskaya et al. (1983b) for D. versicolor. The authors identified isoscoparin based 
on IR, UV, and chemical transformation studies, but did not give any NMR or MS data. 
GC-MS analysis of the carbohydrate unit confirmed glucose, galactose, and rhamnose 
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to be attached either to 4a or 4b. For this reason the structures were established as 
chrysoeriol-6-C-β-D-glucopyranosyl-7-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyra-
noside (isoscoparin-7-O-rutinoside, 4a) and chrysoeriol-6-C-β-D-glucopyranosyl-7-O-
α-L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (isoscoparin-7-O-rhamnosyl-
galactoside, 4b). Both compounds are not published so far. 
Compound 5 was obtained as a yellow amorphous powder, [α]20D -52. HR-ESIMS 
showed an [M-H]¯ ion at m/z 623.1533 (calculated for C28H31O16 623.1638). As for 
compounds 4a and 4b, 1H NMR experiments displayed a characteristic 1H signal at δ 
3.81 with an intensity of 3H, suggesting the presence of an OCH3-group. In the 
anomeric region, two different signals were observed: one anomeric proton at δH 5.50 
with the corresponding 13C signal at 104.4 and another resonance at δH 5.83 (δC 75.1). 
The latter resonances were in perfect accordance with the H-1 and C-1 shift values of 
the C-glucosyl moiety in all compounds discussed before. Acid hydrolysis and GC-MS 
analysis as described above, and 2D NMR analysis revealed the structure of compound 
5 as chrysoeriol-6-C-β-D-glucopyranosyl-7-O-β-D-galactopyranoside (isoscoparin-7-O-
galactoside), which is a new compound. 
Compound 6 was isolated as a yellowish amorphous powder, [α]20D -21. HR-ESIMS 
showed an [M-H]¯ ion at m/z 609.1392 (calculated for C27H29O16 609.1461). NMR data 
of the aromatic part of the molecule were similar to compounds 1 and 2 (isoorientin 
derivatives). In contrast, only one anomeric proton at δ 5.52 with the corresponding 
carbon at δ 104.0 was detected. NMR resonances of the carbohydrate unit were almost 
identical with compound 5. Subsequent acid hydrolysis and GC-MS analysis revealed 
the flavonoid-C-glycoside isoorientin as basic skeleton with a 7-O-linked galactose 
moiety. In conclusion, the structure of 6 was identified as luteolin-6-C-β-D-
glucopyranosyl-7-O-β-D-galactopyranoside (isoorientin-7-O-galactoside), which is a 
new compound.  
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Compound 7 was identified as isovitexin-7-O-glucoside by co-chromatography with an 
authentic sample employing HPLC. Comparison of mass spectra and UV spectra 
obtained with shift reagents (NaOMe, AlCl3, HCl) supported this result. 7 is known as 
saponarin and has been isolated from various species, among them Saponaria officinalis 
(Caryophyllaceae) and Passiflora incarnata (Passifloraceae) (Patel et al., 2009). For D. 
versicolor this compound has not been described so far. 
Compound 8 showed an [M-H]¯ ion at m/z 577.2 which gave prominent fragment ions 
at m/z 457.1, 413.0, and 293.0 in MS2 experiments. This fragmentation can be explained 
by a cross-ring cleavage of the C-glycosylic moiety, the Z-type cleavage of the terminal 
deoxyhexose unit (164 Da), and the combination of both, suggesting a 1→2 linked 
deoxyhexose (Qimin et al., 1991). HPLC and GC-MS analysis after acid hydrolysis 
revealed isovitexin as basic monoglycoside and rhamnose as attached sugar moiety. 
Comparison of 1H and 13C signals of the isolated compound with literature data proved 
8 to be isovitexin-2''-O-rhamnoside, which has been previously found in Crataegus 
species (Rosaceae) (Li et al., 2005), but is new for D. versicolor. 
Compounds 9-16 were compared to reference substances by TLC and HPLC. We 
identified them as apigenin-6-glucoside (isovitexin, 9), luteolin-7-O-glucoside (10), 
apigenin-7-O-glucoside (11), luteolin (12), apigenin (13), chrysoeriol (14), diosmetin 
(15), and acacetin (16). 
 
3. Concluding remarks 
In summary, our phytochemical investigations on the traditional Mongolian medicinal 
plant D. versicolor led to the identification of eighteen flavonoids. The currently 
available phytochemical literature about flavonoids and their structures within the genus 
Dianthus are summarised in Table 1. The comparison showed that the flavonoids found 
in the cultivated species D. caryophyllus are mostly kaempferol-, kaempferide- and 
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quercetin-O-glycosides. In addition, chalcononaringenin-2'-O-glucoside, apigenin-6,8-
diglucoside (vicenin-2), and apigenin-6-C-glucosyl-7-O-(6-malyl-glucoside) were 
reported. All other previously investigated species contain mainly C- or O-
monoglycosides of apigenin, luteolin, and chrysoeriol. So far, isovitexin-4'-O-glucoside 
(isosaponarin) from D. squarrosus as well as from D. pseudosquarrosus and apigenin-
6-C-glucosyl-7-O-(6-malyl-glucoside) from D. caryophyllus are the only C- and O-
diglycosides.identified within the genus Dianthus. Remarkably, half of the D. versicolor 
flavonoids presented in this study are flavonoid-C- and O-glycosides of apigenin, 
luteolin, and chrysoeriol with either two or three sugar moieties. They were isolated 
from a flavonoid enriched fraction of an aqueous extract. This fraction had shown a 
favorable effect by increasing the bile flow in the model of the isolated perfused rat 
liver (Obmann et al., 2010). In the present paper, we characterize the main constituents 
in the respective biologically active fraction of D. versicolor as mainly new flavonoids. 
Nine further flavonoids were identified from the crude aqueous extract. They are known 
compounds but new for Dianthus versicolor. Isovitexin and luteolin-7-O-glucoside have 
been isolated from other Dianthus species before, but all other compounds presented in 
this paper are described for the genus Dianthus for the first time. 
 
4. Experimental 
4.1. Chemicals and reagents 
Reagents for TLC (natural product reagent A, PEG 400) were of analytical grade and 
purchased from Sigma Aldrich (St. Louis, Missouri, USA). MSTFA for the 
derivatization of sugars was purchased from Machery-Nagel GmbH&Co.KG (Dueren, 
Germany). Reference substances for GC, TLC, and HPLC were purchased from Roth 
(Karlsruhe, Germany) and of HPLC quality. Solvents used for extraction were of 
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analytical grade; those used for HPLC were of gradient grade and obtained from VWR 
(West Chester, Pennsylvania, USA). 
 
4.2. General experimental procedures 
Optical rotations were determined by a Polarimeter 341 (PerkinElmer Inc., Waltham, 
Massachusetts, USA) using MeOH as solvent in the following concentrations: 
Compound 1 0.062 g/100 ml, 2 0.015 g/100 ml, 6 0.021 g/100 ml, 7 0.024 g/100 ml. 
UV spectra were recorded online during HPLC analyses using a Prominence SPD-M20 
Diode Array Detector coupled to a Prominence LC-20AD (Shimadzu Corporation, 
Kyoto, Japan). For UV shift-experiments with NaOMe and AlCl3/HCl, spectra were 
recorded in MeOH using a Beckman DU 640 spectrophotometer (Beckman Instruments 
Inc., Fullerton, California, USA). 
NMR spectra were recorded on a Varian Unity Inova 400, 1H at 400 MHz, 13C at 100 
MHz, and a Varian Unity Inova 600, 1H at 600 MHz, 13C at 150 MHz (Varian Inc., Palo 
Alto, California, USA), at 24°C using solutions in pyridine-d5. The TMS resonance was 
used as internal standard. 1H- and 13C-resonances were assigned using 1D proton and 
carbon experiments as well as 2D COSY, HSQC, HSQC-TOCSY, and HMBC 
techniques. The latter were optimized for 8 Hz heteronuclear coupling constant. Spin 
systems were identified in COSY, HSQC, and HSQC-TOCSY spectra. Subsequently, 
these spin systems and the quaternary carbons were connected by correlations found in 
the HMBC experiment. The relative stereochemistry was assigned by selective NOE 
experiments. 1H- and 13C-resonances are numbered as shown in Fig. 3. 
LC-MSn analyses were performed on an UltiMate 3000 RSLC series system (Dionex, 
Germering, Germany) coupled to a 3D quadrupole ion trap instrument equipped with an 
orthogonal ESI source (HCT, Bruker Daltonics, Bremen, Germany) in the negative 
mode. To obtain high resolution masses a MicrOTOF-Q mass spectrometer with ESI 
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ion source (Bruker Daltonics) connected to an UltiMate 3000 series system (Dionex) 
was used in the negative mode. Parameters: nebulizer 30 psi; dry temperature 350°C; 
dry gas 7 l/min; capillary voltage 4000 V; target mass 600 m/z; scan range 150-1000 
m/z. 
For HPLC a 3µm Thermo Aquasil C18 column (150 x 2.1 mm) and a 5µm Thermo 
Aquasil C18 column (250 x 4.6 mm) were used, the latter also for semipreparative 
purposes. Elutions were conducted with different low pressure gradients using doubly 
distilled water (A) adjusted to pH 2.8 with either TFA or HCOOH and MeCN (B). For 
detailed information about the different gradients see section 4.4 HPLC. 
Centrifugal partition chromatography was performed on a CCC-1000 High Speed 
Counter Current Chromatograph (Pharma-Tech Research Corp., Baltimore, Maryland, 
USA). Separation was conducted in tail to head mode using water–n-BuOH–EtOAc 
(2:1:2) as solvent system. TLC analyses were performed at room temperature (22°C) on 
silica gel coated aluminium sheets (TLC Silica gel 60 F254, Merck, Darmstadt, 
Germany) using EtOAc–CH3COOHconc–HCOOHconc–H2O (100:11:11:26) as mobile 
phase. Flavonoid glycosides became visible under UV 366 nm after spraying with 
natural product reagent and PEG 400. 
 
4.2. Plant material 
Samples of Dianthus versicolor FISCH. (Caryophyllaceae) were collected in the 
Mongolian provinces Khubsgul and Khentii in summer 2004 and 2005, and identified 
by E. Ganbold, State University of Mongolia, Ulaanbataar. Herbarium specimens are 
deposited at the Institute of Botany, State University of Mongolia, Ulaanbaatar, 
Mongolia (herbarium numbers 424 and H 20050805). 
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4.3. Extraction and Isolation  
The preparation of an aqueous extract and its subsequent fractionation by solid phase 
extraction (SPE) has been described by Obmann et al. before (Obmann et al., 2010). In 
brief, the dried and powdered aerial parts (100 g) were extracted with 2.5 l doubly 
distilled water adjusted to pH 2 with trifluoroacetic acid (TFA) at 40°C by shaking 
gently. This procedure simulated the traditional way of intake, where the crude 
pulverized drug is taken with plenty of water. After removing the highly volatile TFA 
under reduced pressure at a temperature of 45°C, the remaining solution was freeze 
dried, yielding 21.9 g of aqueous extract. A total amount of 2.4 g aqueous extract was 
further fractionated by SPE: per cartridge 400 mg of aqueous extract were redissolved 
in 1 ml water and applied on C18 material (cartridge: Mega Bond Elut© 60cm3, Varian, 
Zug, CH) previously washed with 1 reservoir volume (RV) MeOH and conditioned with 
1 RV water. The elution was started 10 min after extract application at a drop rate of 1 
ml/min with 3 RV each of water, 10% MeOH (v/v), 40% MeOH (v/v) and 100% 
MeOH. The aqueous fraction was lyophilized, the others were dried under reduced 
pressure at a maximum temperature of 45°C. This procedure gave four fractions 
yielding 987 mg aqueous fraction, 28 mg 10% MeOH fraction, 159 mg 40% MeOH 
fraction and 32 mg 100% MeOH fraction. The 40% MeOH fraction (enriched in 
flavonoid glycosides) was further fractionated by centrifugal partition chromatography 
(CPC). For preparation of solvents water (800 ml), n-BuOH (400 ml) and EtOAc (800 
ml) were mixed in a separation funnel. After separation of the layers, the lower phase 
was taken as stationary phase, and the upper phase was taken as mobile phase. 80 mg of 
40% MeOH fraction were redissolved in 2 ml of a 1:2 mixture of stationary and mobile 
phase and injected. Separation was performed during 8 h at a flow rate of 1.5 ml/min in 
tail to head mode. Fractions of 1.5 ml were collected automatically. After TLC analysis, 
similar fractions were combined to yield 19 subfractions. After the experiment, the 
 43
stationary phase was evaporated to dryness under reduced pressure at 45°C giving 50 
mg dried residue. From this residue compounds 1 (1.16 mg), 2 (1.38 mg), 3 (1.55 mg), 
and 4 (4.16 mg) were isolated by repeated semipreparative HPLC (gradient 4). NMR 
analysis revealed 3 to be a mixture of 3a and 3b. HPLC-MS analyses showed 4 to be a 
mixture of three compounds which co-eluted in the established semipreparative HPLC 
system (gradient 4). Therefore a different separation technique was tried, subjecting 
12.3 g of the aqueous extract to column chromatography using Polyamide (Roth, 
particle size 0.05-0.016 mm) as stationary phase and MeOH-water in different mixing 
ratios as mobile phase. The resulting 177 fractions were combined to 32 subfractions 
according to TLC analysis, and six of them (subfractions I-VI) were used for further 
isolation. Subfraction I (fractions 35-42, 88 mg) eluting with 20% MeOH was further 
purified by semipreparative HPLC (gradient 4) and yielded again the mixtures 3a and 
3b (3.05 mg) as well as 4a and 4b (4.56 mg). Subfraction VI (fractions 137-153, 43 mg) 
eluting with 85% MeOH was purified on Sephadex LH-20 followed by semipreparative 
HPLC (gradient 4) to give 1 mg of compound 7. Subfraction II (fractions 50-55, 31 mg) 
was subjected to column chromatography on Sephadex LH-20. Elution with water 
yielded 40 fractions which were combined to 6 subfractions. Four of these subfractions 
were purified by semipreparative HPLC (gradient 4) and yielded compound 5 (0.78 
mg). Subfraction III (fractions 62-65, 26 mg), subfraction IV (fractions 69-72, 47 mg) 
and subfraction V (fractions 73-81, 149 mg) underwent the same procedure as 
subfraction II and yielded altogether compound 6 (2 mg). Compound 8 (1.62 mg) was 
isolated by semipreparative HPLC (gradient 5) from a fraction obtained by column 
chromatography using silica gel (Merck, Darmstadt, Germany) as stationary phase and a 
mixture of EtOAc–MeOH (9:1) as mobile phase.  
 
 
 44
4.4. HPLC 
For analytical and semipreparative purposes, different low pressure gradients were 
developed. All of them were carried out using doubly distilled water (A) adjusted to pH 
2.8 (TFA) and MeCN (B). For LC-MS analyses, TFA was replaced by HCOOH. Each 
gradient included a final purging step at 95% B for 10 min. Gradient 1 (analytical) was 
conducted at a flow rate of 0.35 ml/min and a column oven temperature of 15°C. It 
started at a concentration of 2% B rising to 14% B within 23 min (rate: 0.52%/min), 
which was followed by an isocratic period for 27 min. Gradient 2 (analytical), at a flow 
rate of 1 ml/min and a column oven temperature of 25°C, started at a concentration of 
15% B which was increased to 45% B within 60 min (rate: 0.5%/min). Gradient 3 
(analytical) started at a concentration of 15% B rising to 20.25% B within 35 min (rate: 
0.15%/min) followed by a slow increase up to 29% in 25 min (rate: 0.35%/min). The 
flow rate was set to 1 ml/min and a column oven temperature of 25°C was held during 
the analysis. Gradient 4 (semipreparative) was employed using a flow rate of 1 ml/min 
and a column oven temperature of 20°C. The starting concentration of 0% B was raised 
to 10% B within 20 min (rate: 0.5%/min), followed by a very slow increase from 10% B 
to 20% B within 60 min (rate: 0.17%/min), and a more rapid one from 20% B to 40% B 
within 20 min (rate: 1%/min). Gradient 5 (semipreparative) started at a concentration of 
17% B rising up to 19.65% B within 18 min (rate: 0.15%/min), followed by an isocratic 
period for 7 min. 
 
4.5. Determination of sugar moieties  
To identify the sugar units and to determine their absolute configuration, the isolated 
flavonoid glycosides were hydrolyzed for 2 h at 100°C using Kiliani reagent (mixture of 
3.5 ml CH3COOHconc, 1 ml HClconc, and 5.5 ml H2O). The solution was extracted three 
times with EtOAc, and the aqueous layer containing monosaccharides was evaporated 
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to dryness. (R)-(-)-2-Butanol and HClconc were added to the residue in order to get the 
corresponding diastereomeric butylglycosides. After 15h at 100°C the solution was 
evaporated to dryness and the residue was prepared for GC-EI-MS analysis by 
derivatization with N-methyl-N-trimethylsilyl-trifluoracetamide. GC-MS analyses were 
performed on a GCMS-QP 2010 (Shimadzu Corporation, Kyoto, Japan) using the 
following parameters: 
GC: Phenomenex ZB-5 capillary column (60 m x 0.25 mm, film thickness 0.25 µm), 
carrier gas: He 5.0, flow rate: 2.0 ml min-1, split ratio 1:10; temperature gradient: 100°C 
to 270°C at a rate of 3°C min-1; injector and interface temperature: 270°C; MS: ion 
source temperature 250°C; electron impact ionization at 70 eV; scan range: 40-500 m/z. 
The monosaccharides were identified by comparison of retention times and mass 
spectra to authentic substances. 
 
4.6. Compound characterization 
 
4.6.1. Luteolin-6-C--D-glucopyranosyl-7-O--L-rhamnopyranosyl-(1→6)--D-gluco-
pyranoside (1) 
Yellow amorphous powder; [α] -48° (c 0.062, MeOH)20.D; 1H and 13C NMR (Table 2); 
HR-ESIMS m/z 755.1993 (calcd for C33H39O20 755.2040) [M-H]¯; Rf=0.12, colour: 
orange (UV 366 nm, natural product reagent); tR=32.49 min (gradient 1) 
 
4.6.2. Luteolin-6-C--D-glucopyranosyl-7-O--L-rhamnopyranosyl-(1→6)--D-galac-
topyranoside (2)  
Slightly yellow amorphous powder; [α] -33° (c 0.015, MeOH)20.D; 1H and 13C NMR 
(Table 2); HR-ESIMS m/z 755.1991 (calcd for C33H39O20 755.2040) [M-H]¯; Rf=0.12, 
colour: orange (UV 366 nm, natural product reagent); tR=33.31 min (gradient 1) 
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4.6.3. Apigenin-6-C--D-glucopyranosyl-7-O--L-rhamnopyranosyl-(1→6)--D-gluco-
pyranoside (3a)  
Yellowish amorphous powder; 1H and 13C NMR (Table 2); HR-ESIMS m/z 739.1993 
(calcd for C33H39O19 739.2091) [M-H]¯; Rf=0.17, colour: greenish (UV 366 nm, natural 
product reagent); tR=39.58 min (gradient 1) 
 
4.6.4. Apigenin-6-C--D-glucopyranosyl-7-O--L-rhamnopyranosyl-(1→6)--D-
galactopyranoside (3b)  
Yellowish amorphous powder; 1H and 13C NMR (Table 2); HR-ESIMS m/z 739.1993 
(calcd for C33H39O19 739.2091) [M-H]¯; Rf=0.17, colour: greenish (UV 366 nm, natural 
product reagent); tR=39.58 min (gradient 1) 
 
4.6.5. Chrysoeriol-6-C--D-glucopyranosyl-7-O--L-rhamnopyranosyl-(1→6)--D-
glucopyranoside (4a) 
Yellow amorphous powder; 1H and 13C NMR (Table 2); HR-ESIMS m/z 769.2171 
(calcd for C34H41O20 769.2197) [M-H]¯; Rf=0.17, colour: greenish (UV 366 nm, natural 
product reagent); tR=43.42 min (gradient 1) 
 
4.6.6. Chrysoeriol-6-C--D-glucopyranosyl-7-O--L-rhamnopyranosyl-(1→6)--D-
galactopyranoside (4b)  
Yellow amorphous powder; 1H and 13C NMR (Table 2); HR-ESIMS m/z 769.2171 
(calcd for C34H41O20 769.2197) [M-H]¯; Rf=0.17, colour: greenish (UV 366 nm, natural 
product reagent); tR=43.42 min (gradient 1) 
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4.6.7. Chrysoeriol-6-C--D-glucopyranosyl-7-O--D-galactopyranoside (5)  
Yellow amorphous powder; [α] -52° (c 0.021, MeOH)20.D; 1H and 13C NMR (Table 2); 
HR-ESIMS m/z 623.1533 (calcd for C28H31O16 623.1638) [M-H]¯; Rf=0.21, colour: 
greenish (UV 366 nm, natural product reagent); tR=41.02 min (gradient 1) 
 
4.6.8. Luteolin-6-C--D-glucopyranosyl-7-O--D-galactopyranoside (6)  
Yellowish amorphous powder, [α] -21° (c 0.024, MeOH)20.D; 1H and 13C NMR (Table 
2); HR-ESIMS m/z 609.1392 (calcd for C27H29O16 609.1461) [M-H]¯; Rf=0.19, colour: 
orange (UV 366 nm, natural product reagent); tR=31.08 min (gradient 1) 
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Table 1 Flavonoids within the genus Dianthus L. 
 
Species Compounds Literature 
Dianthus caryophyllus 
(various cultivars) 
Kaempferide-3-O--D-glucopyranosyl-(1→2)-O-[α-L-rhamnopyranosyl-(1→6)]--D-
glucopyranoside 
Curir et al., 2001 
 Kaempferide-3-O-[2G--D-glucopyranosyl]--rutinoside Curir et al., 2005  
 3-[6-O-(α-L-arabinopyranosyl)--D-glucopyranosyl]-quercetin (Peltatoside) 
3,5,7,2'-Tetrahydroxyflavon (Datiscetin) 
Curir et al., 2003 
 
 Kaempferol-3-(6'''-rhamnosyl-2'''-glucosyl-glucoside) 
Kaempferol-3-(6'''-rhamnosyl-2'''-(6-malyl-glucosyl)-glucoside) 
Apigenin-6-C-glucosyl-7-O-(6-malyl-glucoside) 
Fukui et al., 2003 
 
 Chalcononaringenin 2'-O-glucoside 
 
Yoshida et al., 2004 
Ogata et al., 2004 
 Kaempferol-3-O--D-glucopyranosyl-(1→2)-O--D-glucopyranoside 
Kaempferol-3-O-rutinoside 
Galeotti et al., 2008a 
 
 Apigenin-6,8-di-C--D-glucopyranoside Galeotti et al., 2008b 
 
 Kaempferol-3-O--D-glucopyranosyl-(1→2)-O--D-glucopyranosyl-(1→2)-O-[α-L-
rhamnopyranosyl-(1→6)]--D-glucopyranoside 
Galeotti et al., 2008a 
 Kaempferol-3-O-[α-L-rhamnopyranosyl-(1→6)]--D-glucopyranoside Galeotti et al., 2008b 
 Kaempferol-3-O--D-glucopyranosyl-(1→2)-O-[α-L-rhamnopyranosyl- (1→6)]--D-
glucopyranoside 
Galeotti et al., 2008b 
Galeotti et al., 2008a 
Dianthus arenarius 
Dianthus crinitus 
Dianthus tetralepsis 2 
Luteolin-6-glucoside (isoorientin) 
Luteolin-8-glucoside (orientin) 
Apigenin-6-glucoside (isovitexin) 
Apigenin-8-glucoside (vitexin) 
Luteolin-4'-glucopyranoside 
Apigenin-4'-glucopyranoside 
Boguslavskaya et al., 1983a 
Dianthus hoeltzeri 
Dianthus acicularis 
Apigenin-6-C-syn-α-D-glucopyranoside (neoavroside) 
Apigenin-6-C-anti-α-D-glucopyranoside (isoneoavroside) 
Boguslavskaya et al., 1983a 
Dianthus squarrosus Apigenin-6-C-glucosyl-4'-O-glucoside (isosaponarin) Boguslavskaya et al., 1983a 
                                                 
2 D. tetralepsis is a synonym of D. crinitus (Germplasm Resources Information Network, 2010) 
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Dianthus dicolor 3 
Dianthus ramosissimus 4 
Dianthus versicolor 
Chrysoeriol-6-C-syn-α-D-glucopyranoside 
Chrysoeriol-6-C-anti-α-D-glucopyranoside 
Boguslavskaya et al., 1983a 
Boguslavskaya et al., 1983b 
Dianthus superbus Luteolin-6-glucoside (isoorientin) 
Luteolin-8-glucoside (orientin) 
Seraya et al., 1978 
Dianthus pseudosquarrosus 5 Apigenin-6-glucoside (isovitexin) 
Apigenin-8-glucoside (vitexin) 
Apigenin-6-glucosyl-4’-O-glucoside (isosaponarin) 
Luteolin-7-O-glucoside 
Luteolin-7-O-diglucoside 
Luteolin-5-O-glucoside 
Darmograi and Khimenko, 1978 
Dianthus platyodon Quercetin-3-O-rutinoside (rutin) 
Kaempferol-3-O-(β-D-glucopyranosyl-β-D-glucopyranoside) 
Boguslavskaya, 1976a 
Dianthus deltoides Apigenin-6-C-syn-α-D-glucopyranoside (neoavroside) 
Apigenin-6-C-anti-α-D-glucopyranoside (isoneoavroside) 
Chrysoeriol 
Luteolin 
Luteolin-4'-O-β-D-glucopyranoside 
Chrysoeriol-4'-O-β-D-glucopyranoside 
Boguslavskaya and Beletskii, 1978 
 
Boguslavskaya et al., 1976b 
 
 
                                                 
3 D. dicolor is probably a spelling mistake, instead, D discolor exists according to IPNI, which is also stated as D. chinensis (The International Plant 
Name Index, 2010a) 
4 D. ramosissimus is referred to as D. ramosissimum according to Grubov (2001) 
5 D. pseudosquarrosus is also stated as D. arenarius f. pseudosquarrosus (The International Plant Name Index, 2010b) 
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Table 2. 1H and 13C NMR data for 1, 2, 3a, 3b, 4a, 4b, 5, 6 in pyridine-d5 (J in Hz) 
 1  2  5  6  
position C, mult. H (J in Hz) C, mult. H (J in Hz) C, mult. H (J in Hz) C, mult. H (J in Hz) 
2 165.7, qC  165.8, qC  164.9, qC  165.3, qC  
3 104.3, CH 6.86, br s 104.5, CH 6.87, br s 104.5, CH 6.95, s 104.0, CH 6.94, s 
4 183.0, qC  183.1, qC  183.3, qC  183.1, qC  
5 161.4, qC  161.5, qC  161.2, qC  161.5, qC  
6 112.0, qC  112.0, qC  112.1, qC  111.9, qC  
7 164.2, qC  164.5, qC  164.3, qC  164.1, qC  
8 94.5, CH 7.02, br s 94.8, CH 7.04, br s 95.3, CH 7.27, s 94.7, CH 7.09, s 
9 157.6, qC  157.7, qC  157.5, qC  157.4, qC  
10 106.6, qC  106.7, qC  106.4, qC  106.4, qC  
1’ 122.6, qC  122.8, qC  122.4, qC  122.8, qC  
2’ 114.5, CH 8.00, br s 114.6, CH 7.99, d (2.1) 110.5, CH 7.57, br s 114.6, CH 7.88, d (2.0) 
3’ 147.8, qC  147.7, qC  149.2, qC  148.0, qC  
4’ 152.1, qC  152.1, qC  153.0, qC  152.2, qC  
5’ 117.3, CH 7.43, d (8.4) 117.4, CH 7.44, d (8.4) 117.1, CH 7.23, d (8.6) 116.7, CH 7.25, d (8.3) 
6’ 120.1, CH 7.56, d (8.4) 120.4, CH 7.56, dd (8.4, 2.1) 121.5, CH 7.55, d (8.6) 119.5, CH 7.46, d (8.3) 
OCH3     56.2, CH3 3.81, s   
6C-Glc-1’’ 74.8, CH 5.78, d (9.6) 75.0, CH 5.77, d (9.7) 75.1, CH 5.83, d (10.0) 74.7, CH 5.81, d (9.7) 
2 72.9, CH 5.16, m 73.0, CH 5.12, t (9.1) 73.2, CH 5.20, t (9.3) 72.8, CH 5.22, m 
3 80.9, CH 4.40, t (9.1) 81.1, CH 4.37, t (9.0) 81.2, CH 4.40, t (9.4) 80.8, CH 4.42, m 
4 71.5, CH 4.57, t (9.2) 71.7, CH 4.44, m 71.5, CH 4.56, m 71.1, CH 4.56, m 
5 83.0, CH 4.11, m 83.3, CH 4.12, m 83.0, CH 4.10, m 82.6, CH 4.09, m 
6 62.0, CH2 
 
4.48, m 
4.61, dd (11.7, 4.1) 
62.3, CH2 4.51, m 
4.57, m 
62.7, CH2 4.47, m 
4.61, m 
62.1, CH2 4.50, m 
4.62, m 
7O-Glc-1’’’ 103.5, CH 5.43, d (7.5)       
2 75.1, CH 4.19, t (8.5)       
3 77.7, CH 4.26, m       
4 71.3, CH 3.92, t (9.3)       
5 77.3, CH 4.28, m       
6 67.9, CH2 
 
4.10, m 
4.83, m 
      
7O-Gal-1’’’   104.8, CH 5.36, d (7.7) 104.4, CH 5.50, d (7.6) 104.0, CH 5.52, d (7.6) 
2   72.7, CH 4.79, m 72.9, CH 4.83, t (8.7) 72.5, CH 4.86, m 
3   74.5, CH 4.26, m 75.0, CH 4.25, dd (9.7, 3.6) 74.5, CH 4.31, m 
4   70.4, CH 4.42, m 70.3, CH 4.56, m 69.9, CH 4.62, m 
5   76.4, CH 4.34, m 78.3, CH 4.32, m 77.9, CH 4.36, m 
6   68.2, CH2 4.46, m 
4.49, m 
62.3, CH2 
 
4.47, m 
4.61, m 
61.7, CH 4.46, m 
4.62, m 
Rha-1’’’’ 102.4, CH 5.58, br s 102.7, CH 5.52, br s     
2 72.0, CH 4.80, m 72.3, CH 4.80, m     
3 73.0, CH 4.73, dd (8.9, 3.4) 73.2, CH 4.71, m     
4 73.8, CH 4.31, t (9.2) 74.0, CH 4.32, t (9.1)     
5 70.0, CH 4.35, m 70.1, CH 4.35, m     
6 18.5, CH3 1.63, d (6.0) 18.7, CH3 1.67, d (5.8)     
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 3a  3b  4a  4b  
position C, mult. H (J in Hz) C, mult. H (J in Hz) C, mult. H (J in Hz) C, mult. H (J in Hz) 
2 165.3, qC  165.3, qC  165.2, qC  165.2, qC  
3 104.2, CH 6.87, s 104.2, CH 6.87, s 104.4, CH 6.92, s 104.4, CH 6.92, s 
4 183.2, qC  183.2, qC  183.2, qC  183.2, qC  
5 161.5, qC  161.5, qC  161.6, qC  161.6, qC  
6 112.1, qC  112.1, qC  112.1, qC  112.1, qC  
7 164.3, qC  164.5, qC  164.3, qC  164.4, qC  
8 94.9, CH 7.12, s 94.9, CH 7.12, s 94.8, CH 7.16, s 94.8, CH 7.16, s 
9 157.6, qC  157.6, qC  157.7, qC  157.7, qC  
10 106.7, qC  106.7, qC  106.6, qC  106.6, qC  
1’ 122.2, qC  122.2, qC  122.4, qC  122.4, qC  
2’ 129.4, CH 8.03, m 129.4, CH 8.03, m 110.4, CH 7.57, m 110.4, CH 7.57, m 
3’ 117.5, CH 7.47, m 117.5, CH 7.47, m 149.2, qC  149.2, qC  
4’ 163.2, qC  163.2, qC  152.9, qC  152.9, qC  
5’ 117.5, CH 7.47, m 117.5, CH 7.47, m 117.6, CH 7.58, m 117.6, CH 7.58, m 
6’ 129.4, CH 8.03, m 129.4, CH 8.03, m 121.9, CH 7.81, m 121.9, CH 7.81, m 
OCH3     56.3, CH3 3.88, s 56.3, CH3 3.86, s 
6C-Glc-1’’ 75.1, CH 5.79, d (9.7) 75.1, CH 5.78, d (9.7) 74.9, CH 5.80, d (9.7) 75.0, CH 5.79, d (9.7) 
2 73.1, CH 5.18, t (9.1) 73.0, CH 5.13, t (9.1) 73.0, CH 5.19, t (9.2) 72.9, CH 5.15, t (9.2) 
3 81.1, CH 4.40, m 81.1, CH 4.37, m 81.1, CH 4.39, m 81.1, CH 4.37, m 
4 71.6, CH 4.58, t (9.1) 71.7, CH 4.46, m 71.6, CH 4.57, t (9.4) 71.6, CH 4.47, t (9.4) 
5 83.2, CH 4.11, m 83.2, CH 4.11, m 83.1, CH 4.10, m 83.1, CH 4.10, m 
6 62.3, CH2 4.47, m 
4.61, m 
62.3, CH2 4.49, m 
4.58, m 
62.2, CH2 4.47, m 
4.60, m 
62.2, CH2 4.47, m 
4.60, m 
7O-Glc-1’’’ 103.8, CH 5.50, d (7.5)   103.6, CH 5.51, d (7.4)   
2 75.3, CH 4.20, t (8.5)   75.3, CH 4.20, t (8.4)   
3 77.9, CH 4.27, m   77.8, CH 4.22, m   
4 71.3, CH 3.98, t (9.3)   71.2, CH 3.98, t (9.2)   
5 77.8, CH 4.31, m   77.7, CH 4.24, m   
6 68.0, CH2 4.17, m 
4.78, m 
  67.8, CH2 4.18, m 
4.74, m 
  
7O-Gal-1’’’   104.7, CH 5.42, d (7.6)   104.5, CH 5.43, d (7.6) 
2   72.7, CH 4.77, m   72.6, CH 4.78, t (8.6) 
3   74.3, CH 4.26, m   74.4, CH 4.28, m 
4   70.2, CH 4.46, m   70.0, CH 4.45, m 
5   76.2, CH 4.35, m   76.0, CH 4.31, m 
6   67.8, CH2 4.41, m 
4.51, m 
  67.4, CH2 4.35, m 
4.53, m 
Rha-1’’’’ 102.8, CH 5.59, br s 102.6, CH 5.48, br s 102.6, CH 5.59, br s 102.4, CH 5.49, br s 
2 72.4, CH 4.74, m 72.4, CH 4.74, m 72.3, CH 4.70, m 72.3, CH 4.70, m 
3 73.0, CH 4.60, m 73.0, CH 4.60, m 72.9, CH 4.57, m 72.9, CH 4.57, m 
4 74.3, CH 4.26, m 74.3, CH 4.26, m 74.2, CH 4.24, m 74.2, CH 4.24, m 
5 70.1, CH 4.35, m 70.1, CH 4.35, m 69.9, CH 4.36, m 69.9, CH 4.36, m 
6 18.7, CH3 1.63, d (6.0) 18.8, CH3 1.67, d (6.0) 18.7, CH3 1.63, d (6.1) 18.7, CH3 1.67, d (6.1) 
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Figure 1. HPLC-analysis of the aqueous extract of Dianthus versicolor employing 
gradient 1 (1A), gradient 2 (1B), and gradient 3 (1C). Peak numbers 
correspond to the compounds listed in Figure 2. 
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Figure 2. Chemical structures of compounds 1-16 (Gal: galactose, Glc: glucose, Rha: 
rhamnose) 
 
 
 
 
 
 
 
 
 
Figure 3. Characteristic HMBC correlations of 1 
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Fig S1. UV spectra of compounds 1-6 and 8 recorded online in 14% MeCN (1-6) or 
31% MeCN (8) 
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Cpd λmax (nm) λmin (nm) 
   
1 256 (sh), 268, 347 243, 298 
2 256 (sh), 268, 347 243, 297 
3a+3b 269, 335 247, 298 
4a+4b 255 (sh), 269, 347 243, 260, 297 
5 256 (sh), 269, 345 245, 299 
6 256 (sh), 269, 347 243, 298 
8 269, 337 245, 294 
Table S1. UV data of 1-6 and 8 
S3 
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Table S2. MSn data of compounds 1-8: 
 
Cpd [M+H]+ [M-H]- Main Fragment Ions (>10%) in -DDA 
    
1 757.2 755.3 MS2 [755.3]: 447.1, 356.9, 326.9, 298.9 
MS3 [447.1]: 356.9, 326.9, 298.9 
MS3 [326.9]: 298.9 
2 757.2 755.3 MS2 [755.3]: 755.3, 635.2, 489.0, 447.1, 357.0, 326.9, 298.9 
MS3 [635.2]: 399.0, 326.9, 298.9, 298.0 
MS3 [447.1]: 356.9, 326.9, 299.0 
MS3 [326.9]: 298.9 
3a +3b 741.2 739.3 MS2 [739.3]: 431.1, 310.9 
MS3 [431.1]: 340.9, 310.9, 282.9 
MS3 [310.9]: 282.9 
4a+4b 771.2 769.3 MS2 [769.3]: 461.1, 340.9, 297.9 
MS3 [461.1]: 371.0, 341.0, 297.9 
MS3 [340.9]: 297.9 
5 625.2 623.3 MS2 [623.3]: 503.2, 461.1, 371.0, 341.0, 297.9 
MS3 [461.1]: 371.0, 340.9, 297.9 
MS3 [341.0]: 325.9, 312.9, 297.9 
6 611.2 609.3 MS2 [609.3]: 447.1, 357.0, 326.9, 298.9 
MS3 [447.1]: 356.9, 326.9, 299.0 
MS3 [326.9]: 298.9 
7 595.2 593.3 MS2 [593.3]: 473.1, 431.1, 341.0, 310.9, 282.9 
MS3 [431.1]: 340.9, 310.9, 282.9 
MS3 [310.9]: 282.9 
8 579.1 577.2 MS2 [577.2]: 457.1, 413.0, 293.0 
MS3 [457.1]: 311.0, 282.0 
MS3 [413.1]: 293.0 
MS3 [293.0]: 174.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S4
 62
Figure S2. 1H NMR spectrum of 1 
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Figure S3. DQFCOSY of 1 
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Figure  S4. HSQC of 1 
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Figure  S5. HMBC of 1 
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Figure  S6. 1H NMR spectrum of 2 
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Figure S7. HSQC of 2 
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Figure S8. HMBC of 2 
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Figure S9. 1H NMR spectrum of 3a+3b 
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Figure S10. DQFCOSY of 3a+3b 
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Figure S11. HSQC of 3a+3b 
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Figure S12. HMBC of 3a+3b 
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Figure S13. 1H NMR spectrum of 4a+4b 
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Figure S14. DQFCOSY of 4a+4b 
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Figure S15. HSQC of 4a+4b 
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Figure S16. HSQC-TOCSY of 4a+4b 
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Figure S17. HMBC of 4a+4b 
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Figure S18. 1H NMR spectrum of 5 
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Figure S19. GCOSY of 5 
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Figure S20. HSQC of 5 
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Figure S21. HMBC of 5 
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Figure S22. 1H NMR spectrum of 6 
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Figure S23. DQFCOSY of 6 
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Figure S24. HSQC of 6 
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Figure S25. HMBC of 6 
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3.2 Analytical section 
 
The quantification of flavonoid-glycosides by HPLC-DAD and UV-
spectrophotometry is described in the following manuscripts “Quantification of 
flavonoid glycosides from the traditional Mongolian medicinal plant 
Dianthus versicolor FISCH.”, accepted for publication in Journal of Separation 
Science [23] on 17th November 2010 and “HPLC-Determination of flavonoid 
glycosides in Mongolian Dianthus versicolor Fisch. (Caryophyllaceae) 
compared to quantification by UV-spectrophotometry”, in preparation to be 
submitted for publication to Phytochemical analysis [24]. The development and 
validation of the analytical HPLC-DAD methods as well as the sample analyses 
and calculations were carried out by Astrid Obmann at the Department of 
Pharmacognosy, University of Vienna. HPLC-MSn-analyses and interpretation 
of the MS-spectra were performed at the Department of Pharmacognosy by 
Martin Zehl together with Astrid Obmann. The quantification of flavonoids by 
UV-spectrophotometry was done by Astrid Obmann. 
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Abstract 
An HPLC-DAD method was established in order to investigate dried aerial parts of 
Dianthus versicolor FISCH. (Caryophyllaceae), a plant used in traditional Mongolian 
medicine against liver impairment. Aqueous extracts were separated on an Aquasil® C18 
column with a linear gradient of acetonitrile (ACN) and water (adjusted to pH 2.8 with 
formic acid) as mobile phase. LC-IT-MS facilitated the assignment of 26 flavonoids, 
among them a series of rare C-glycosylated as well as O-glycosylated derivatives, 
which are assumed to be the active principles. Quantification was performed and 
validated using isovitexin-7-O-glucoside (saponarin) as external standard. The method 
showed good linear behaviour (r2 0.9999) over the investigated concentration range 
(0.007-3.5 mg/mL). The good precision of the method allowed the successful 
qualitative and quantitative analysis of flavonoid-glycosides in the aqueous extracts 
prepared from five different D. versicolor samples. Depending on the origin of the 
samples, the total flavonoid content was found to vary considerably from 0.41% to 
3.30% in the aqueous extracts and from 0.07 to 0.57% in the crude drug. In addition, the 
relative composition of the various flavonoids was found to differ strongly. These 
results highlight the need for proper quality control for this herbal drug. 
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1 Introduction 
Dianthus versicolor FISCH. (Caryophyllaceae) is a medicinal plant well known in 
traditional Mongolian medicine. In Mongolian literature it is reported that it influences 
the blood pressure and is used to treat cardiovascular diseases by traditional physicians 
[15]. Due to its property to increase the contractility of the uterus, D. versicolor is used 
against bleeding after birth and against strong bleeding during menstruation [15]. It is 
furthermore known to be beneficial in pneumonia, typhoid fever, and poisoning [2]. Its 
actions include diuretic and antiinflammatory effects, and, despite its staunching 
properties, it may cause bleeding when overdosed [3]. Another indication, although 
scientifically less studied, comprises impairments of the liver as reported by a very 
reputed traditional health institution [4]. Support for this use was obtained by recent 
investigations in the model of the isolated perfused rat liver [6]. According to the 
“Report of market research on Mongolian traditional medicinal drugs” prepared in 
September 2007 for the WHO [3], D. versicolor ranks among the 45 most common 
domestic herbal drugs traded in Mongolia. With an average price of about € 3,- per 
kilogram on the local markets [3], it belongs to one of the most expensive domestic 
drugs in Mongolia. Scientific data about its pharmacology and phytochemistry are 
scarce. The plant has been shown to contain a series of pentacyclic triterpenoid saponins 
[5]. Our investigations have shown that an aqueous extract and a flavonoid-enriched 
fraction of D. versicolor cause an increase of bile flow in the isolated perfused rat liver 
[6]. Bioactivity-guided fractionation led to the isolation and structure elucidation a 
number of flavonoids [7]. However, to date neither methods for qualitative analysis of 
these active constituents nor methods to quantify the flavonoids in D. versicolor have 
been reported. 
In this paper, five plant samples of D. versicolor, collected in different years and 
different Mongolian regions, are compared by TLC and HPLC. TLC analysis provides a 
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quick overview and showed strong variations in the relative concentration of the main 
flavonoids in the five aqueous extracts. Metabolite profiling was performed by LC-MSn 
which enabled the identification of flavonoid-glycosides with up to three sugar moieties. 
In order to quantify these substances, a new HPLC-DAD method was developed using 
saponarin as external standard. 
The validated method allows the simultaneous quantitative determination of 26 
flavonoids in D. versicolor and was successfully applied to compare the flavonoid 
pattern of five different samples. 
 
2 Materials and methods 
2.1 Chemicals and reagents 
The reagents for TLC were natural product reagent A (diphenylboric acid-2-amino-
ethylester) and PEG 400. They were of analytical grade and purchased from Sigma 
Aldrich (St. Louis, Missouri, USA). Saponarin was purchased from Roth (Karlsruhe, 
Germany; batch 21896936, HPLC purity 100% according to enclosed certificate). 
Solvents used for extraction were of analytical grade, those used for HPLC were of 
gradient grade and obtained from VWR (West Chester, Pennsylvania, USA). 
 
2.2 Plant material 
Aerial parts of five D. versicolor FISCH. batches (a-e) were collected in different 
Mongolian provinces. The plant material was identified by E. Ganbold, Health Sciences 
University, Mongolia. The denomination of the species bases on Grubov [8]. Voucher 
specimens are kept in the Department of Pharmacognosy, University of Vienna, Austria, 
herbarium numbers 03/04/mon/H (b), 14/03/mon/H (d, e) and in the Institute of Botany, 
Mongolian Academy of Sciences, Ulaanbaatar, Mongolia, herbarium numbers 424 (a) 
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and H 20050805 (c). For details concerning region and year of collection see supporting 
information (see Table S1). 
 
2.3 Preparation of extracts 
For phytochemical investigations aqueous extracts of all five D. versicolor samples 
were prepared according to a method we had described earlier [6]. Briefly, 10 g of the 
dried aerial parts were powdered and extracted with 250 mL water (pH 2, adjusted with 
trifluoroacetic acid) for 1h at 40°C by shaking gently. This procedure is intended to 
resemble the physiologic processes taking place after the consumption of the crude 
herbal drug which is taken together with a certain amount of water. After extraction the 
highly volatile trifluoroacetic acid was removed under reduced pressure at a maximum 
temperature of 45°C and the remaining solution was lyophylised. The yields are given 
as drug to extract ratio (DER).  
 
2.4 TLC analysis 
TLC served as a quick method to compare the flavonoid fingerprints of the D. 
versicolor samples. Silica gel 60 F254 coated aluminium sheets (Merck, Darmstadt, 
Germany) were used as stationary phase. The mobile phase was a mixture of 
ethylacetate, formic acidconc, acetic acidconc and water (100:11:11:26 v/v/v/v). 
Visualisation was performed by spraying with a 1% methanolic solution of natural 
product reagent A followed by a 5% ethanolic solution of PEG 400 under UV 366nm. 
 
2.5 HPLC-DAD and HPLC-DAD-MSn conditions 
Qualitative and quantitative HPLC-DAD analyses of the aqueous extracts were 
conducted on a Prominence LC-20AD coupled to a Prominence SPD-M20 Diode Array 
Detector (Shimadzu Corporation, Kyoto, Japan). For data analysis the software 
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LabSolutions version 1.25, LC-Postrun (Shimadzu, Kyoto, Japan) was used. Peaks were 
integrated automatically by the method of vertical separation applying the following 
parameters: the minimum peak width was set at 5 sec, at a slope of 1000 µV/min, and a 
minimum peak area of 14450 units according to the LOQ for saponarin. The 
wavelength was set at 340 nm for detection in accordance with the maximum absorption 
of the flavonoids measured by DAD (see Fig. S1). An Aquasil® C18 column (4.6 mm x 
250.0 mm, 5µm, Thermo Fisher Scientific, Waltham, Massachusetts) served as 
stationary phase. Doubly distilled water adjusted to pH 2.8 with formic acid (A) and 
ACN (B) were used as mobile phase at a flow rate of 1.0 mL/min. Separations were 
carried out at a column oven temperature of 15°C. The developed gradient could not 
provide baseline separation of the polar compounds but allowed an adequate separation 
of all constituents in a reasonable time: 15% B to 23.75% B within 58 min (rate: 
0.15%/min) followed by an increase up to 29% B within 15 min (rate: 0.35%/min) (see 
Fig. 1). 
The LC-MS analyses were performed on an UltiMate 3000 RSLC-series system 
(Dionex, Germering, Germany) coupled to a 3D quadrupole ion trap mass spectrometer 
equipped with an orthogonal ESI source (HCT, Bruker Daltonics, Bremen, Germany). 
HPLC separation was carried out as described above. The eluent flow was split roughly 
1:8 before the ESI ion source, which was tuned as follows: capillary voltage: +3.7 kV 
(i.e. negative ion mode), nebulizer: 30 psi (N2), dry gas flow: 8 L/min (N2), and dry 
temperature: 340 °C. The mass spectrometer was operated in an automated data-
dependent acquisition (DDA) mode where each MS scan (m/z 120-1000, average of 5 
spectra) was followed by MS2, MS3 and MS4 scans (m/z 40-1000, average of 3 spectra, 
isolation window of 4 Th, fragmentation amplitude of 1.0 V) of the two most intense 
precursor ions in the previous scan (provided that they were detected with sufficient 
intensity). 
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Sample preparation: 0.1 g of the aqueous extracts was redissolved in 5.0 mL of 
methanol-water (40:60, v/v). The solution was treated in the ultrasonic bath for 10 min 
at room temperature. After centrifugation at 13500 rpm for 10 min, 40 µL of the sample 
solution was subjected to HPLC analysis. 
 
3 Results and discussion 
3.1 General 
The aim of our research was to provide appropriate methods for the qualitative and 
quantitative analysis of the flavonoids in the Mongolian medicinal plant D. versicolor. 
Such tools represent the basis for the quality control of this traditionally used medicinal 
herb and its remedies. 
The TLC-comparison (see Fig. S2) of the five samples showed two types of 
fingerprints differing in the number and ratio of detected flavonoids. Samples a and b 
were characterised by spots up to Rf values of 0.28, whereas in samples c, d, and e 
additional fluorescent bands were located in a much less polar range from Rf 0.32 to 1.0. 
The HPLC analyses confirmed this result (see Fig. 1). The respective peaks were 
identified or characterised by LC-MS (see Table 1 and section 3.2). The quantification 
method was developed using saponarin as external standard (see section 3.3). 
 
3.2 Characterisation of compounds 
Based on the HPLC fingerprint, 26 major flavonoid constituents were selected for the 
quantitative analysis. The structures of 13 compounds have been elucidated following 
bioactivity-guided fractionation in a previous study [7], and are shown in Fig. 2. 
Identification of the remaining components was based on their characteristic UV and 
MSn spectra [9]. 
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According to TLC and HPLC analyses, the samples a and b are mainly characterised by 
highly polar flavonoids (Fig. 1 and Table 1, compounds 1-11). Nine of them have 
earlier been isolated by our group and found to be C- and O-glycosides of apigenin, 
luteolin, and chrysoeriol. They all possess a C-glycopyranosyl group at position 6 and 
an additional mono- or disaccharide bound to the hydroxyl-group at position 7 (Fig. 2). 
Compound 4, which was detected as [M-H]- ion at m/z 725.2, showed a predominant 
neutral loss of 116 Da in MS2 that is attributed to the loss of a malyl-group. Further CID 
experiments on the resulting fragment ion at m/z 609.2 yielded spectra that are identical 
to those of luteolin-6-glucopyranosyl-7-O-galactopyranoside (1), allowing the 
identification of compound 4 as a luteolin-C-hexosyl-O-hexoside malyl-ester (Table 1 
and Fig. S3). Analogously, compound 11 was identified as a malyl-ester of apigenin-C-
hexosyl-O-hexoside. Apigenin-6-C-glucosyl-7-O-(6-malyl-glucoside), together with 
several malyl-esters of glycosylated anthocyanins, have previously been isolated from D. 
caryophyllus [10]. 
In sample c, those compounds could also be detected, but were of much lower 
abundance. Instead, a series of less polar flavonoids predominated, which were 
identified as either C- or O-glycosides of apigenin, luteolin, and 3’- or 4’-methylluteolin 
(Fig. 1 and Table 1, compounds 12-26). C-hexosides showed typical neutral losses of 90 
and 120 Da due to cross-ring cleavage of the carbohydrate moiety (0,3X0- and 0,2X0- ions, 
respectively), whereas O-linked deoxyhexosyl-hexosides, hexosides, and hexuronides 
are characterized by the neutral loss of 308, 162, and 176 Da (Y0- ions), respectively 
[11]. The aglyca were identified by comparison of the respective mass spectra with an 
in-house library containing mass data of 57 flavonoids (Fig. S4). 
The remaining two samples, d and e, contained all the above mentioned compounds at 
comparable levels. 
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3.3 Quantification of flavonoids 
 
3.3.1 Optimisation of chromatographic conditions 
As is evident from Table 1 and Figure 2, the main flavonoid components in the aqueous 
extracts of D. versicolor are structurally highly similar, with some of them differing 
only in the isomerism of a sugar unit. Consequently, the chromatographic separation is 
highly challenging and a practical method must be a compromise between the achieved 
degree of separation and a reasonable analysis time. For the same reason existing 
methods for the quantification of flavonoids in other Dianthus species [12] could not be 
applied. Various stationary phases were tested such as Phenomenex® Luna Phenyl-
Hexyl, LiChrospher® 100 RP-18e, and Aquasil® C18, with the latter leading to most 
satisfactory results. Trials at various column temperatures, above and below room 
temperature, showed 15°C to be optimal. This gradient is a compromise providing 
separation of most of the 26 compounds, although with rather low resolution for some 
peak pairs, at acceptable retention times. 
 
3.3.2 Method validation 
The method was validated with respect to linearity, accuracy and precision following 
the ICH guidelines on validation of analytical methods [13]. 
 
3.3.2.1 Calibration curve, LOD and LOQ 
Isovitexin-7-O-glucoside (saponarin) was chosen as external standard. It is present in all 
investigated samples of D. versicolor and commercially available. As a flavonoid 
diglycoside with a molecular weight of 594 Da it matches very well with the other 
flavonoids found in D. versicolor, whose molecular weights ranged between 432 Da 
and 770 Da (see Table 1). For assessing the linearity, six different concentrations of 
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saponarin ranging from 0.007-3.5 mg/mL were examined in triplicates. The least square 
line and the correlation coefficient were calculated and showed the method to be linear 
(r2>0.9999; linear regression equation y = 22279996x - 42847). The standard deviation 
of the y-intercept (sa) was calculated to be 72352. 
The LOD and LOQ for saponarin under the chromatographic conditions were 
determined at the S/N of 3 and 10, showing values of 0.05 µg/mL and 0.17 µg/mL, 
respectively.  
 
3.3.2.2 Response factors 
The content of each compound to be quantified was calculated considering the peak 
areas of the analytes and those of the external standard as well as the concentration of 
the sample and the standard solution. Since the majority of the quantified compounds 
was not commercially available, the response factors were calculated based on the ratios 
of the molecular weights. It has been shown that the response factors of compounds 
with the same chromophor (see Fig. S1) are directly proportional to their molecular 
weights [14]. Consequently, the molecular weight of each analyzed compound was 
compared to the molecular weight of the standard saponarin (594 Da). This procedure 
follows the European Pharmacopoeia which provides mathematical corrections as 
described above, e. g. for the quantification of Ginkgo folium by HPLC [15]. The 
obtained response factors ranged between 0.73 and 1.30 (see Table S2) and were 
included in the above mentioned calculation. Therefore, this method allows not only the 
determination of the total flavonoid content but also the estimation of single compounds. 
 
3.3.2.3 Accuracy 
The accuracy of this newly developed method was investigated by comparison to an 
established UV spectrophotometric method from the European Pharmacopoeia that was 
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slightly modified as published earlier [6]. For this, samples a and c have been analysed 
with both methods in triplicates. The total flavonoid content as determined by the HPLC 
method was 107.3% for sample a and 91.9% for sample c compared to the UV method. 
 
3.3.2.4 Precision 
For determination of the inter- and intra-day variability, nine solutions of the aqueous 
extract of sample a were individually prepared. Three samples were analyzed per day in 
three consecutive days. Variations were expressed by the relative standard deviations 
(RSD) which were less than 2.0% and demonstrated a good precision and repeatability 
of the proposed method. The results are summarised in Table 3.  
 
3.4 Sample analysis 
The established HPLC method was applied to determine the flavonoid content in the 
aqueous extracts of five different D. versicolor samples. Those aqueous extracts were 
prepared by mimicking gastric conditions (see section 2.3). The flavonoid contents in 
the corresponding crude drugs were recalculated on basis of the yields given as DER 
and represent minimum values since the extraction efficiency was not evaluated (see 
Table 2). The HPLC fingerprints (Fig. 1) showed a comparable qualitative composition 
of the five samples but revealed substantial quantitative differences. For example, the 
content of luteolin-6-glucopyranosyl-7-O-galactopyranoside (1) ranges from 0.02% in 
samples b and d to 0.26% in sample c. Apigenin-6-glucopyranosyl-2''-O-rhamnoside 
(12) could only be quantified in the samples c (0.70%), d (0.05%), and e (0.02%), but 
was below the LOD in the samples a and b. In general, the extracts of samples a and b 
contained predominantly flavonoid glycosides of higher polarity with two or three sugar 
moieties attached, whereas in samples c, d, and e mainly monoglycosides were detected. 
The aqueous extracts of samples a and c were characterised by high total flavonoid 
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contents (1.91% and 3.30 %, respectively), whereas the total contents of the others were 
remarkably low, ranging from 0.41% to 0.52%. This might be due to differences in 
habitat and climate between the five collection sites. These results highlight the need for 
proper quality control for this herbal drug. 
 
4 Concluding remarks 
In the present study, a new HPLC-UV method was developed for the quantification of 
26 flavonoids in the aqueous extract of D. versicolor using saponarin as external 
standard. The examined aqueous extracts had been shown to give a positive impact on 
bile secretion [6]. Therefore, the quantified flavonoids can be regarded as markers for 
the quality assessment of D. versicolor. The method was validated and showed good 
linearity, accuracy, and precision. Thus, it is highly suitable for the quality control of 
this herbal drug. 
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Figure 1. HPLC comparison of five different D. versicolor aqueous extracts. The 
indicated numbers correspond to the substances listed in Table 1. 
Figure 2. Chemical structures of the known flavonoid glycosides in D. versicolor 
 Legend: Gal: -D-galactose, Glc: -D-glucose, Rha: -D-rhamnose 
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Table 1. Compounds 1-26 listed according to the HPLC fingerprints (Fig. 1) including molecular mass and MSn fragmentation patterns. 
Compounds denoted in italics are tentatively identified based exclusively on UV- and MS-data. 
 
 Compound Name or Proposed Structure Mr [M-H]- Main Fragment Ions (>10% rel. Int.) 
1 Luteolin-6-glucopyranosyl-7-O-galactopyranoside 610 609.2 MS2 [609.2]: 489.1, 447.1, 357.0, 327.0, 299.0 
MS3 [447.1]: 357.0, 327.0, 299.0 
MS3 [327.0]: 298.9 
2 Luteolin-6-glucopyranosyl-7-O-rutinoside 756 755.3 MS2 [755.3]: 635.1, 447.1, 357.0, 327.0, 298.9 
MS3 [447.1]: 357.0, 327.0, 299.0 
MS3 [327.0]: 298.9 
3 Luteolin-6-glucopyranosyl-7-O-rhamnopyranosyl-
galactopyranoside 
756 755.3 MS2 [755.3]: 635.1, 447.1, 357.0, 327.0, 298.9 
MS3 [447.1]: 357.0, 327.0, 299.0 
MS3 [327.0]: 298.9 
4 Luteolin-C-hexosyl-O-hexoside malyl-ester 726 725.2 MS2 [725.2]: 609.2 
MS3 [609.2]: 489.1, 447.1, 357.1, 327.0, 299.0 
MS4 [447.1]: 357.0, 327.0, 299.0 
MS4 [327.0]: 298.9 
5 Apigenin-6-glucopyranosyl-7-O-glucopyranoside 594 593.2 MS2 [593.2]: 473.1, 431.1, 341.1, 311.0, 296.9, 283.0 
MS3 [431.1]: 341.0, 311.0, 282.9 
MS3 [311.0]: 282.9 
6 
 
Apigenin-6-glucopyranosyl-7-O-rutinoside 
 
740 739.3 MS2 [739.3]: 431.1, 310.9 
MS3 [431.1]: 341.0, 310.9 
MS3 [310.9]: 282.9 
7 Apigenin-6-glucopyranosyl-7-O-rhamnopyranosyl-
galactopyranoside 
740 739.3 MS2 [739.3]: 431.1, 310.9 
MS3 [431.1]: 341.0, 310.9 
MS3 [310.9]: 282.9 
8 
 
Chrysoeriol-6-glucopyranosyl-7-O-galactopyranoside 
 
624 623.2 MS2 [623.2]: 503.1, 461.1, 371.1, 341.1, 297.9 
MS3 [461.1]: 370.9, 341.0, 297.9 
MS3 [341.1]: 326.0, 297.9 
9 
 
Chrysoeriol-6-glucopyranosyl-7-O-rutinoside 
 
770 769.3 MS2 [769.3]: 461.1, 371.1, 341.0, 298.0 
MS3 [461.1]: 371.0, 341.0, 297.9 
MS3 [340.9]: 312.9, 297.9 
10 Chrysoeriol-6-glucopyranosyl-7-O-rhamnopyranosyl-
galactopyranoside 
770 769.3 MS2 [769.3]: 461.1, 371.1, 341.0, 298.0 
MS3 [461.1]: 371.0, 341.0, 297.9 
MS3 [340.9]: 312.9, 297.9 
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11 Apigenin-C-hexosyl-O-hexoside malyl-ester 710 709.2 MS2 [709.2]: 593.2, 431.1, 311.0 
MS3 [593.2]: 473.1, 431.1, 341.0, 311.0, 282.9 
MS3 [431.1]: 341.0, 310.9, 282.9 
MS4 [310.9]: 282.9 
12 Apigenin-6-glucopyranosyl-2''-O-rhamnoside 578 577.2 MS2 [577.2]: 457.1, 413.1, 292.9 
MS3 [413.1]: 292.9 
MS3 [292.9]: 248.8, 238.7, 236.8, 220.9, 219.8, 174.7, 172.7, 116.9 
13 Apigenin-6-glucoside 432 431.1 MS2 [431.1]: 341.0, 311.0, 283.1 
MS3 [341.0]: 323.0, 310.9, 294.9, 282.9, 281.9, 280.9, 268.9 
MS3 [311.0]: 282.9 
14 Luteolin-O-(deoxyhexosyl-hexoside) 594 593.2 MS2 [593.2]: 284.9 
MS3 [284.9]: 266.8, 242.8, 241.8, 240.8, 222.8, 216.8, 212.8, 200.7, 198.8, 
196.7, 174.8, 170.7, 168.8, 150.7, 132.8 
15 Chrysoeriol-C-hexosyl-2''-O-deoxyhexoside 608 607.2 MS2 [607.2]: 443.1, 323.0, 308.0 
MS3 [443.1]: 323.0, 308.0 
MS3 [323.0]: 307.9 
MS4 [307.9]: 279.9 
16 
 
Luteolin-7-O-glucoside 448 447.1 MS2 [447.1]: 284.9 
MS3 [284.9]: 266.9, 256.9, 256.0, 242.7, 240.8, 212.8, 200.7, 198.7, 197.8, 
196.6, 174.7, 168.9, 150.7 
17 
 
Luteolin-O-hexuronide 462 461.1 MS2 [461.1]: 284.9 
MS3 [284.9]: 243.0, 240.9, 216.9, 201.9, 200.7, 198.9, 197.9, 197.0, 174.9, 
154.7, 132.9 
18 Chrysoeriol-C-hexoside 462 461.1 MS2 [461.1]: 371.1, 341.0, 298.0 
MS3 [341.0]: 312.9, 297.9 
19 Apigenin-O-(deoxyhexosyl-hexoside) 578 577.2 MS2 [577.2]: 268.9 
MS3 [268.9]: 224.7, 223.8, 196.8, 182.7, 180.7, 150.7, 116.9 
20 3’- or 4’-Methylluteolin-O-(deoxyhexosyl-hexoside) 608 607.2 MS2 [607.2]: 298.9, 283.9 
MS3 [298.9]: 283.9 
MS3 [283.9]: 255.7 
21 Apigenin-7-O-glucoside 432 431.1 MS2 [431.1]: 268.8 
22 Apigenin-O-hexuronide 446 445.1 MS2 [445.1]: 268.9, 174.7 
MS3 [268.9]: 224.8, 200.8, 180.8, 158.7, 148.8, 116.8 
23 3’- or 4’-Methylluteolin-O-(deoxyhexosyl-hexoside) 608 607.2 MS2 [607.2]: 298.9, 283.9 
MS3 [298.9]: 283.9 
MS3 [283.9]: 255.9 
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24 3’- or 4’-Methylluteolin-O-hexoside 462 461.1 MS2 [461.1]: 446.0, 313.0, 298.9, 298.0, 284.9, 283.9, 282.9 
MS3 [446.0]: 312.9, 296.9, 284.9, 283.9, 282.9, 254.8, 243.7 
MS3 [298.9]: 283.9 
25 3’- or 4’-Methylluteolin-O-glucuronide 476 475.1 MS2 [475.1]: 298.9, 283.9 
MS3 [298.9]: 283.9 
MS4 [283.9]: 255.8 
26 3’- or 4’-Methylluteolin-O-hexoside 462 461.1 MS2 [507.1] ([M+HCOO]- ion): 461.0, 298.9  
MS3 [461.0]: 298.9 
MS3 [298.9]: 283.9 
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Table 2. Total flavonoid contents of five D. versicolor samples 
 
Sample Aqueous extract Crude drug DER 
a 1.91 (± 0.03) ≥ 0.40 (± 0.01) 1:0.213 
b 0.41 (± 0.03) ≥ 0.07 (± 0.00) 1:0.163 
c 3.30 (± 0.05) ≥ 0.57 (± 0.02) 1:0.168 
d 0.50 (± 0.03) ≥ 0.08 (± 0.00) 1:0.158 
e 0.52 (± 0.03) ≥ 0.08 (± 0.00) 1:0.162 
 
Legend: 
The total flavonoid contents are given in % ±  SD of the mean. The flavonoid contents are calculated as 
the sum of the 26 individually quantified flavonoids. The total flavonoid contents of the crude drug are 
calculated considering the respective DER and represent minimum values since the extraction efficiency 
was not evaluated. 
 
Table 3. Precision of the quantification method 
 
Sample  Flavonoid content (%) Intraday RSD (%) Interday RSD (%) 
a (n=9) 1.85   
 1.90   
 1.92 1.91  
 1.90   
 1.89   
 1.90 0.30  
 1.92   
 1.96   
 1.92 1.19 1.22 
 
Figure 1. HPLC comparison of five different D. versicolor aqueous extracts. The 
indicated numbers correspond to the substances listed in Table 1 
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Figure 2. Chemical structures of the known flavonoid glycosides in D. versicolor (Gal: 
-D-galactose, Glc: -D-glucose, Rha: -D-rhamnose) 
 
 
 
 
 
 
 R R1 R2 Common name 
1 OH Glc Gal Isoorientin-7-O-galactoside 
2 OH Glc Rha(16)Glc Isoorientin-7-O-rutinoside 
3 OH Glc Rha(16)Gal Isoorientin-7-O-rhamnosyl-galactoside 
5 H Glc Glc Isovitexin-7-O-glucoside (saponarin) 
6 H Glc Rha(16)Glc Isovitexin-7-O-rutinoside 
7 H Glc Rha(16)Gal Isovitexin-7-O-rhamnosyl-galactoside 
8 OCH3 Glc Gal Isoscoparin-7-O-galactoside 
9 OCH3 Glc Rha(16)Glc Isoscoparin-7-O-rutinoside 
10 OCH3 Glc Rha(16)Gal Isoscoparin-7-O-rhamnosyl-galactoside 
12 H Rha(12)Glc H Isovitexin-2''-O-rhamnoside 
13 H Glc H Isovitexin 
16 OH H Glc Luteolin-7-O-glucoside 
21 H H Glc Apigenin-7-O-glucoside 
O
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Figure S1.  UV-spectra and structures of the compounds 2, 5, and 8. The three chromophores differ only 
by the presence of an additional OH- or OCH3-group in position 3’. 340 nm represents a mean value of 
the maxima (334 nm and 347 nm) and was therefore chosen as detection wavelength. 
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Figure S2. TLC fingerprints of the five D. versicolor aqueous extracts. 
     d          e          c         b         a 
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Figure S3. Multistage mass spectra (LC-ESI-IT-MSn) of compound 4 (luteolin-C-hexosyl-O-
hexoside malyl-ester) and luteolin-6-glucopyranosyl-7-O-galactopyranoside (1). Left panel: (A) MS1, 
(B) MS2 (725.2 ), (C) MS3 (725.2  609.2 ), (D) MS4 (725.2  609.2  447.1 ), and (E) MS4 
(725.2  609.2  327.0 ) mass spectra of compound 4. Right panel: (A) MS1, (B) MS2 (609.2 ), (C) 
MS3 (609.2  447.1 ), and (D) MS3 (609.2  327.0 ) mass spectra of luteolin-6-glucopyranosyl-7-
O-galactopyranoside (1). Note that, following cleavage of the malyl-group from 4, the two compounds 
show identical fragmentation patterns. 
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Figure S4. Multistage mass spectra (LC-ESI-IT-MSn) of compound 14 (luteolin-O-(deoxyhexosyl-
hexoside)). (A) MS1, (B) MS2 (593.2 ), and (C) MS3 (593.2  284.9 ) mass spectra of compound 
14. The aglycon was identified by matching the MS3 spectrum of 14 (C) to the MS3 (447.0  284.9 ) 
mass spectrum of luteolin-4'-O-glucoside (D) from an in-house library containing MS data of 57 
flavonoids. 
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Sample Collection number Collection site and year Herbarium number 
(Dept. of Pharmacognosy, 
University of Vienna) 
Herbarium number 
(Inst. of Botany, Mongolian 
Academy of Sciences, Ulaanbaatar) 
a 53/04/mon Khubsgul, August 2004  424 
b 52/04/mon Bulgan, August 2004 03/04/mon/H  
c 02/05/mon  Khentii, August 2005  H 20050805 
d 05/03/mon  Selenge, July 2003 14/03/mon/H  
e 06/03/mon Selenge, July 2003 14/03/mon/H  
 
Table S1. Plant material 
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Sample a (aqueous extract)   
Compound Content (%) Response factor Corrected content (%) 
1 0.10 1.03 0.10 
2 0.22 1.27 0.28 
3 0.21 1.27 0.27 
4 0.05 1.22 0.07 
5 0.05 1 0.05 
6+7 0.13 1.25 0.17 
8 0.11 1.05 0.12 
9+10 0.46 1.3 0.59 
11 0.22 1.2 0.27 
Total content (%)   1.91 
 
Sample c (aqueous extract)   
Compound Content (%) Response factor Corrected content (%) 
1 0.25 1.03 0.26 
3 0.08 1.27 0.10 
9+10 0.07 1.3 0.09 
12 0.72 0.97 0.70 
13 0.14 0.73 0.10 
14 0.42 1 0.42 
15 0.43 1.02 0.44 
16 0.34 0.75 0.26 
17+18 0.17 0.78 0.13 
19 0.14 0.97 0.14 
20+21 0.17 0.88 0.15 
22 0.12 0.75 0.09 
23+24 0.28 0.9 0.25 
25 0.13 0.80 0.10 
26 0.09 0.78 0.07 
Total content (%)   3.30 
 
 
Table S2. Contents of single compounds and total flavonoid content in the aqueous extracts of 
samples a and c. 
 
Content (%) = MassStandard * PeakareaAnalyte * 100 / MassExtract * PeakareaStandard  
 
Corrected content (%) = Content * Response Factor 
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HPLC Determination of flavonoid glycosides in Mongolian 
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Reznicek1, Samdan Narantuya2, Sabine Glasl1 
1Department of Pharmacognosy, University of Vienna, Althanstrasse 14, 1090 Vienna, 
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2Health Sciences University of Mongolia, Ulaanbaatar PO 48 Box 111, Mongolia 
 
Abstract: 
Introduction – Dianthus versicolor, a plant used in traditional Mongolian medicine, is 
known to contain flavone-6-C-7-O-di- and triglycosides. Reliable and accurate 
analytical methods are needed for their determination in the crude drug and extracts 
thereof. 
Objective – To provide a validated HPLC-DAD method especially developed for the 
separation of polar flavonoids and to compare the obtained data with those evaluated by 
UV-spectrophotometry. 
Results – Separations were carried out on an Aquasil® C18 column (4.6 mm x 250.0 mm) 
with acetonitrile and water (adjusted to pH 2.8 with formic acid) as mobile phase. 
Linear gradient elution was employed using rutoside as internal standard with linear 
behaviour in a concentration range of 0.007-3.5 mg/mL. Accuracy was determined by 
spiking the crude drug with saponarin resulting in recoveries between 92% and 102%. 
The method allows the quantification of highly polar flavonoid glycosides and the 
determination of their total content. The latter was evaluated by 0.45% for the crude 
drug, by 1.73% for the aqueous extract and by 16.29% for the enriched fraction. In case 
of an identical flavonoid glycoside spectrum in the extracts UV spectrophotometry was 
shown to match the contents determined by HPLC. It was proven that threefold 
sonication represents a time-saving, effective and cheap method for the extraction of the 
polar flavonoid glycosides. 
Conclusion – The HPLC method represents a powerful technique for the quality control 
of D. versicolor. Extraction experiments showed sonication to be superior to refluxing. 
UV-spectrophotometry may be regarded as acceptable alternative to HPLC. 
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Medicine; flavonoids; HPLC-UV-DAD; spectrophotometric quantification 
 
Introduction 
Dianthus versicolor FISCH. (Caryophyllaceae) is one of the five Dianthus species 
growing in Mongolia (Grubov, 2001) and is used in traditional Mongolian medicine 
(Kletter, 2008). Its indications are manifold and include e. g. inflammation, pneumonia, 
typhoid fever, poisoning, impairments of the liver, and womb´s bleeding (Boldsaikhan 
2004; Ligaa 2006; Report of Market Research on Mongolian Traditional Medicinal 
Drugs 2007; Dr. Damdinsuren Natsagdorj, Otoch Manramba, Institute of Traditional 
Mongolian Medicine, Ulaanbaatar, personal communication). Recent investigations 
have shown an aqueous extract of D. versicolor as well as a flavonoid enriched fraction 
thereof to enhance bile secretion in the isolated perfused rat liver (Obmann et al. 2010a). 
The constituents were identified as C- and O-glycosylated apigenin-, luteolin-, and 
chrysoeriol-derivatives (Obmann et al. 2010b). The quantification of the flavone-6-C-7-
O-glycosides in this aqueous extract was performed by HPLC and external 
standardisation (Obmann et al. 2010b). The occurrence of drug samples containing a big 
amount of highly polar flavonoids required the development of an alternative system. 
For this purpose the extraction procedure was optimized. A new HPLC-UV-DAD 
method was developed and validated using rutoside as internal standard. Furthermore 
we determined the content of the highly polar flavonoid glycosides in the crude drug, in 
the aqueous extract and in the enriched fraction (see Fig. 1). In order to provide an 
additional simple and low-cost procedure for quantification in laboratories which are 
possibly not equipped with an HPLC device, we employed UV-spectrophotometry. The 
results obtained by HPLC were compared to the UV method in order to give evidence 
about the comparability of the two methods. 
 
Experimental 
Material, chemicals and reagents 
Reagents for UV-spectrophotometric quantification (boric acid, oxalic acid) were of 
analytical grade and purchased from Sigma Aldrich (St. Louis, Missouri, USA). 
Reference substances purchased from Roth (Karlsruhe, Germany) were of HPLC 
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quality. Solvents used for extraction were of analytical grade, those used for UV-
spectrophotometry and HPLC were of gradient grade and obtained from VWR (West 
Chester, Pennsylvania, USA). 
 
Plant material 
Aerial parts of Dianthus versicolor were collected in the Mongolian province of 
Hövsgöl, August 2004. The plant material was identified by E. Ganbold, Health 
Sciences University, Mongolia. A voucher specimen (herbarium specimen number 424) 
is deposited at the Institute of Botany, Mongolian Academy of Sciences, Ulaanbaatar, 
Mongolia. 
 
Spectrophotometric procedure 
Instrumentation. Spectrophotometric measurements were performed on a Beckman 
DU 640 spectrophotometer (Beckman Instruments Inc., Fullerton, California, USA) 
equipped with 1 cm quartz cells. 
Stock solutions. For the preparation of stock solutions the crude drug, the dry aqueous 
extract, and the enriched fraction were treated as follows:  
Crude drug: 0.5 g of the dry pulverized plant material was extracted with 40 mL 
methanol-water (40:60, v/v) for 30 min under reflux. The extract solution was filtered 
and the residue was re-extracted repeating the extraction procedure two times for 10 
min. After filtration the solutions were unified and diluted to 100.0 mL with methanol-
water (40:60, v/v).  
Dry aqueous extract: 0.2 g of the lyophilized aqueous extract was re-extracted with 40 
mL methanol-water (40:60, v/v) for 10 min by sonication. After filtration, 40 mL of 
fresh solvent were added to the pellet, which was treated a second time by sonication 
for 10 min. The resulting solutions were combined and diluted to 100.0 mL.  
Enriched fraction: 0.02 g of the dry material was dissolved in 100.0 mL methanol-water 
(40:60, v/v). 
Compensation liquid. 5.0 mL of the stock solution were evaporated to dryness, and the 
residue was redissolved in 10 mL methanol-acetic acidconc (1+10, v/v). Instead of the 
reagent (see sample preparation) 10 mL of formic acidconc were added, and the solution 
was further diluted to 25.0 mL with acetic acidconc. 
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Sample preparation. 5.0 mL of each stock solution were evaporated to dryness, and 
the residue was redissolved in 10 mL methanol-acetic acidconc (1+10, v/v). 10 mL of 
reagent (25 g/L boric acid and 20 g/L oxalic acid in formic acidconc) were added, and the 
solution was further diluted to 25.0 mL with acetic acidconc. After 30 min, the absorption 
of the sample at 401 nm was measured against the compensation liquid. The percentage 
content of flavonoids was calculated and expressed as 8-C-glucosyl-apigenin (vitexin) 
based on the specific absorbance of vitexin, i. e. 628 (European Pharmacopoeia, 2008). 
Each assay was carried out with at least three different sample weights. 
 
HPLC analysis 
Sample preparation of the crude drug. 0.2 g of the crude drug was extracted three 
times with 20 mL of methanol-water (40:60, v/v) by sonication at room temperature for 
10 min. The solutions were combined and after addition of 50 µL of the standard 
solution (20.0 mg/ 5 mL rutin in MeOH) evaporated to dryness under reduced pressure 
at a maximum temperature of 45°C. The residue was redissolved in 5.0 mL of 
methanol-water (40:60, v/v). From this solution 40 µl were subjected to HPLC-analysis 
after centrifugation. 
Sample preparation of the aqueous extract. The aqueous extract was obtained as 
previously described (Obmann et al. 2010a). In brief, 10 g of the powdered aerial parts 
were extracted with 250 mL water (pH 2, adjusted with trifluoroacetic acid) for 1h at 
40°C by shaking gently. This procedure is intended to resemble the physiologic 
processes taking place after the consumption of the crude herbal drug which is taken 
together with a certain amount of water. After extraction the highly volatile 
trifluoroacetic acid was removed under reduced pressure at a maximum temperature of 
45°C. The remaining solution was lyophylized and yielded 2.16 g of the aqueous extract. 
For HPLC analysis 0.1 g of the aqueous extract was redissolved in 5.0 mL of methanol-
water (40:60, v/v) followed by an addition of 50 µL of the standard solution (17.83 mg/ 
5 mL rutin in MeOH). After centrifugation at 13500 rpm for 10 min 40µl of the sample 
solution were subjected to HPLC analysis. 
Sample preparation of the enriched fraction. The enriched fraction was obtained by 
solid phase extraction of the aqueous extract on RP18 cartridges as described earlier 
(Obmann et al. 2010a). For HPLC analysis to 0.01 g of the dried fraction 50µl of 
standard solution (17.5 mg/ 5 mL rutin in MeOH) were added and diluted to 0.5 mL 
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with methanol-water (40:60, v/v). After centrifugation at 13500 rpm for 10 min 20µl of 
the sample solution were subjected to HPLC analysis.  
 
Analytical conditions. Quantification of flavonoids was conducted on a Shimadzu 
Prominence LC-20AD coupled to a Shimadzu Prominence SPD-M20 Diode Array 
Detector (Shimadzu Corporation, Kyoto, Japan). For data analysis the software 
LabSolutions version 1.25, LC-Postrun (Shimadzu, Kyoto, Japan) was used. Peaks were 
integrated automatically by the method of vertical separation applying the following 
parameters: the minimum peak width was set at 5 sec, at a slope of 1000 µV/min, and a 
minimum peak area of 9900 units according to the LOQ for rutoside. The wavelength 
was set at 340 nm for detection in accordance with the maximum absorption of the 
flavonoids measured by DAD. An Aquasil® C18 column (4.6 mm x 250.0 mm, 5µm, 
Thermo Fisher Scientific, Waltham, Massachusetts) served as stationary phase. Doubly 
distilled water adjusted to pH 2.8 with formic acid (A) and ACN (B) were used as 
mobile phase at a flow rate of 1.0 mL/min. Separations were carried out at a column 
oven temperature of 15°C. A low pressure gradient was used starting at 0% B and 
raising up to 10% B within 20 min (0.5%/min) followed by three further gradient steps: 
First a very slow increase from 10% B to 20% B within 60 min (0.17%/min), then from 
20% B to 40% B within 20 min (1%/min) and finally from 40% B up to 95% B within 
10 min (5.5%/min). 
 
Results and Discussion 
Chromatographic separation 
Among the various C18 materials that were tested for the separation of the 11 flavone-6-
C-7-O-glycosides Aquasil® with a particle size of 5 µm and a column dimension of 4.6 
mm x 250 mm turned out to be most appropriate. On the one hand this stationary phase 
achieved the best separation and on the other hand columns of this dimension are still 
most common in laboratories. In order to shorten the retention time analyses were 
carried out on Aquasil® C18 material with a particle diameter of 3 µm at column 
dimensions of 2.1 mm x 150 mm. However, as this resulted in a remarkably lower 
resolution of the compounds 2, 3, 6+7 and 8 we decided to choose the long column with 
a higher separation efficiency but long time of analysis. Compounds 6 / 7 and 
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compounds 9 / 10 represent pairs of substances which differ only by a glucose and 
galactose unit, respectively (see Fig. 1 and Fig. 2). They co-elute and are determined 
together. 
In order to be independent from the injection by an autosampler or from concentration 
effects occurring during sample preparation we focussed on the development of a 
method with an internal standard. Rutoside (quercetin-3-O-rutinoside, see Fig. 1) was 
chosen as internal standard because it is cheap and similar to the compounds 
investigated but not contained in Dianthus versicolor. As a flavonoid diglycoside with a 
molecular weight of 610 it matches very well with the molecular weights we found for 
the flavonoids in Dianthus versicolor. 
 
Effects of extraction assay and optimisation of extracting conditions 
The extraction procedure and selection of the proper solvent are crucial factors in 
quantitative phytochemical analysis. Two different extraction assays, refluxing and 
ultrasonication, were applied to investigate the effectiveness of the extraction procedure. 
Sonication turned out as the more powerful extraction technique (see Fig. 3). Singular 
ultrasonication for 10 min at room temperature achieved the same content as three fold 
heating under reflux which took in total 50 min. All together we obtained a maximum 
total content after treating the plant material for three times in the ultrasonic bath. The 
first extraction step provides a yield of 89%, the second step yields another 9% and the 
third time 2% of the total content (see Fig. 3). The results show that threefold 
ultrasonication represents a time-saving, effective and cheap method for the extraction 
of the flavonoid-glycosides from Dianthus versicolor. 
 
Method validation, calibration curves, accuracy and precision 
Out of the flavonoid-glycosides to be analysed only compound 5 (saponarin) was 
commercially available. Therefore, we determined the response factor for saponarin in 
comparison to the internal standard rutoside and calculated the response factors of the 
other compounds by taking their molecular weight into account. It has been shown that 
the response factors of compounds with the same chromophor are directly proportional 
to their molecular weights (Reznicek et al. 1996). The correctness of this approach 
implies the selection of an appropriate detection wavelength at which all constituents 
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are registered equally. The analytes in Dianthus versicolor represent C- and O-
glycosides of apigenin, luteolin (3’-OH-apigenin) and chrysoeriol (3’-OCH3-apigenin) 
whose absorption maxima range between 334 nm and 347 nm (Obmann et al. 2010b). 
Therefore, the detection wavelength for quantification was set at 340 nm. We 
experimentally evaluated the response of the three aglycones at 340 nm by injecting 
equal amounts and found high similarity of the molar responses with a maximum 
deviation of 5.9%.  
For assessing the linearity six different concentrations of rutoside and saponarin ranging 
from 0.007-3.5 mg/mL were examined in triplicates. The least square lines and the 
correlation coefficients were calculated and proved the method to be linear (rutoside: 
r2>0.9998; linear regression equation: y=14858531x – 223566; saponarin: r2>0.9999; 
linear regression equation y = 22279996x - 42847). 
The response factor of saponarin was determined by mixing varying amounts (0.007-3.5 
mg/mL) with 0.07 mg/mL rutoside. The average response factor of saponarin was 
evaluated by 0.72 (afr). On basis of this response factor the response factors of all other 
identified compounds were evaluated arithmetically as described above. Accordingly, 
the response factors of compounds 1-11 are given in Table 1. Amounts were calculated 
by the following equation: afr/MW(saponarin)*MW(compound). 
The LOD and LOQ for rutoside and saponarin under the chromatographic conditions 
were determined at the S/N of 3 and 10, respectively. The LOD for rutoside and 
saponarin were 0.2µg/mL and 0.05 µg/mL, and the LOQ were 0.7 µg/mL and 0.17 
µg/mL, respectively. 
The accuracy of the method was investigated by means of recovery experiments spiking 
the crude drug with different concentrations of saponarin dissolved in methanol. Known 
saponarin amounts were added at low (50% of the known amount in the sample), 
medium (same amount as in the sample) and high (150% of the known amount in the 
sample) levels. Analyses were performed in triplicates. The recoveries were evaluated 
by 91.8% ( 7.2% RSD), 92.1% ( 7.4 RSD) and 101.9% ( 4.1 RSD). 
The intermediate precision of the developed method was determined by preparing 
independently nine methanolic-aqueous extracts of the crude drug. The analyses were 
performed on different days with a relative standard deviation (RSD) of 4.8% (see 
Table 1) which demonstrated a good precision of the method. 
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Sample analyses 
The above described HPLC method allows the determination of the single polar 
flavonoid glycosides on the one hand and the quantification of the total content on the 
other hand (see Table 1). The total content of the flavonoid glycosides in the crude drug 
amounted to 0.45%. The aqueous extract represents the way of intake by mimicking 
gastric conditions during the extraction process. This extraction procedure resulted in a 
concentration of polar flavonoids up to an amount of 1.73%. Further purification of this 
aqueous extract by SPE yielded an enriched fraction which has been shown to increase 
the bile secretion in the isolated perfused rat liver (Obmann et al. 2010a). The total 
content of flavonoid glycosides in this fraction was determined by 16.29% with the 
compounds 2, 3, 9 and 10 at the highest concentrations. We compared these results to 
the values obtained by UV-spectrophotometry which respresents a quick and cheap 
method to determine the content of all flavonoids, either glycosides or aglycones. The 
respective method has been published earlier for D. versicolor (Obmann 2010a). It was 
developed following the monograph “Passiflorae herba” of the European 
Pharmacopoeia (European Pharmacopoeia, 2008), because the basic structures of the 
main flavonoids in Passiflora (Patel, 2009, Quimin, 1991) resemble to those isolated 
from Dianthus versicolor. For the crude drug a content of 0.75% was determined. This 
corresponds to more than the 1.5fold of the value obtained by HPLC and may be 
explained by the fact that aglycones which are co-extracted by methanol-water were not 
compassed by the HPLC method. In comparison, the contents determined by both 
methods in the aqueous extract and in the enriched fraction were in good agreement. For 
the aqueous extract a value of 1.73% analysed by HPLC corresponded very well with 
1.78% determined by UV-spectrophotometry. Also the contents of the enriched fraction 
fit together with 16.59% determined by UV-spectrophotometry and 16.29% evaluated 
by HPLC. 
 
Conclusion 
The presented data contribute to the scientific investigation of herbal drugs applied in 
traditional Mongolian medicine. The techniques described in this paper may be 
regarded as basic methods for quality control of D. versicolor. The proposed HPLC 
method shows good linearity, accuracy and precision and achieves a better separation of 
the polar flavonoid glycosides than an earlier published method. Alternatively, a simple 
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UV spectrophotometric method was employed. It was slightly modified according to a 
monograph of the European Pharmacopoeia and showed contents which matched very 
well the values obtained from HPLC-DAD analysis. UV-spectrophotometry may be 
regarded as acceptable alternative in case that no HPLC device is available. In terms of 
extraction efficiency sonication was superior to refluxing. Threefold sonication with 
methanol 40% represents a time-saving, effective and cheap method for the extraction 
of the polar flavonoid glycosides from Dianthus versicolor. 
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Table 1. Content of flavonoids in the crude drug, an aqueous extract and a flavonoid 
enriched fraction of Dianthus versicolor determined by HPLC-DAD and UV-
spectrophotometry  
 
Compound number  Crude drug 
(n=9) 
Aqueous 
extract (n=9) 
Enriched 
fraction (n=3) 
 Response  
factor 
Single compounds 
(mean %,  ± SD) 
  
1 0.74 0.03 (± 0.003) 0.09 (± 0.002) 0.97 (± 0.065) 
2 0.91 0.05 (± 0.005) 0.25 (± 0.007) 2.30 (± 0.028) 
3 0.91 0.04 (± 0.004) 0.24 (± 0.007) 2.20 (± 0.029) 
4 0.88 0.03 (± 0.003) 0.06 (± 0.002) 0.78 (± 0.072) 
5 0.72 0.02 (± 0.001) 0.04 (± 0.002) 0.58 (± 0.062) 
6+7 0.90 0.05 (± 0.003) 0.15 (± 0.013) 1.53 (± 0.016) 
8 0.88 0.03 (± 0.005) 0.11 (± 0.009) 1.13 (± 0.067) 
9+10 0.93 0.08 (± 0.004) 0.54 (± 0.015) 4.45 (± 0.541) 
11 0.86 0.12 (± 0.005) 0.25 (± 0.007) 2.36 (± 0.089) 
Total content HPLC 
(mean %, ± RSD) 
 0.45 (± 4.79) 1.73 (± 2.45) 16.29 (± 4.11) 
Total content UV 
(mean %, ± RSD) 
 0.75 (± 2.68) 1.78 (± 2.90) 16.59 (± 1.43) 
 
 124  
Figure 1. Chemical structures of flavonoid glycosides in D. versicolor (Gal: -D-galactose, 
Glc: -D-glucose, Rha: -D-rhamnose, Hex: hexose) and of the internal standard rutoside 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. HPLC-fingerprints of the crude drug extracted with MeOH/water (40/60, v/v) 
(1), the aqueous extract (2), and the flavonoid enriched fraction (3). The peak numbers 
correspond to the compounds listed in Fig xx. Peak 12 represents the internal standard 
rutin. 
 
 
 
 R R1 R2 Common name 
1 OH Glc Gal Isoorientin-7-O-galactoside 
2 OH Glc Rha(16)Glc Isoorientin-7-O-rutinoside 
3 OH Glc Rha(16)Gal Isoorientin-7-O-rhamnosyl-galactoside 
4 OH Hex Hex-malyl Luteolin-C-hexosyl-O-hexoside malylester 
5 H Glc Glc Isovitexin-7-O-glucoside (saponarin) 
6 H Glc Rha(16)Glc Isovitexin-7-O-rutinoside 
7 H Glc Rha(16)Gal Isovitexin-7-O-rhamnosyl-galactoside 
8 OCH3 Glc Gal Isoscoparin-7-O-galactoside 
9 OCH3 Glc Rha(16)Glc Isoscoparin-7-O-rutinoside 
10 OCH3 Glc Rha(16)Gal Isoscoparin-7-O-rhamnosyl-galactoside 
11 H Hex Hex-malyl Apigenin-C-hexosyl-O-hexoside malylester 
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Figure 3. Optimization of the extraction method 
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Legend: The upper panel compares the total content of flavonoids after extraction with a 
mixture of MeOH/water (40/60, v/v) under reflux (RF 3x, 30 min each), extraction for 
one time by ultrasound (U 1x, 10 min), and extraction for three times by ultrasound (U 
3x). For each of the extraction modes three individual samples were tested. The lower 
panel compares the three extraction steps (Extr 1, Extr 2, Extr 3) by ultrasound (U 3x). 
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3.3 Biological section 
 
In this section the biological investigation of aqueous extracts and fractions of D. 
versicolor are described. The influence on the bile flow was examined in the 
model of the isolated perfused rat liver. Those results are summarized in the 
publication “Extracts from the Mongolian traditional medicinal plants 
Dianthus versicolor FISCH. and Lilium pumilum DELILE stimulate bile flow 
in an isolated perfused rat liver model” published in Journal of 
Ethnopharmacology [21]. 
The aqueous extract of D. versicolor and fractions thereof were prepared and 
phytochemically analysed by Astrid Obmann. The quantification of flavonoids 
was done by Astrid Obmann. Phytochemical analyses of Lilium pumilum were 
performed by Ines Offenmüller under supervision of Astrid Obmann and are part 
of her Diploma thesis. The liver perfusions were carried out at the Institute of 
Pathophysiology, Medical University of Vienna by the group of Theresia 
Thalhammer. Test solutions were prepared by Astrid Obmann. The evaluation 
of the results in the isolated perfused rat liver was done by Astrid Obmann 
together with Theresia Thalhammer and Sabine Glasl. 
 
The results of the investigations on isolated organ preparations are contained in 
the diploma thesis of Birgit Weisz-Pecher [29], the effects on the uterus are 
shown on the poster “Uterus activity of the Mongolian medicinal plant 
Dianthus versicolor FISCH.” [31] (Appendix, p.167). Extracts and fractions for 
those analyses were prepared by Astrid Obmann, the investigations on the 
isolated organ preparations were carried out by Birgit Weisz-Pecher and Pakiza 
Rawnduzi at the Department of Pharmacology and Toxicology, University of 
Vienna. 
 127  
 
 128  
 
 129  
 
 130  
 
 131  
 
 132  
 
 133  
 134  
3.4 Additional analyses and optimization of methods 
 
This chapter mentions additional TLC and GC-MS analyses as well as the 
optimization of HPLC-methods which is not described in detail in publications 1-
4 [21, 22, 23,24].  
3.4.1 TLC 
 
TLC was used to get a quick overview of compound classes in the OWE of D. 
versicolor. In first trials the aqueous extracts of five different samples (Table 1, p. 
19) were compared in a system suitable for flavonoid-glycosides (system 1, 
chapter 2.3.1 p. 24, table 3). These investigations showed that the aqueous 
extracts of samples a and b were rich in highly polar compounds characterized 
by Rf-values up to 0.28 (Fig. 8). In the samples c, d, and e less polar flavonoids 
(Rf > 0.4) were detected in addition to the polar ones known from samples a 
and b. Differences in the types of aglycones were indicated by appearance of 
orange (luteolin-type) or greenish (apigenin-type, chrysoeriol-type) spots after 
spraying with natural product reagent/ PEG 400, which is highly suitable for the 
detection of phenolic compounds, and detection under UV 366 nm.  
 
 
 
Based on these results, in addition to the HPLC method for the quantification of 
flavonoids in all five samples described in publication 3 [23] an alternative 
method was developed for the analysis of the OWEs of samples a and b [24]. 
     d          e          c         b         a 
Fig. 8 TLC analysis of the OWE 
(chapter 2.2.1, p. 19) of samples a-e 
applying system 1 (chapter 2.3.1 p. 24, 
table 3) detected with natural product 
reagent/PEG 400, UV 366 nm 
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System 1 was furthermore used for the analysis of fractions obtained by SPE 
(Fig. 9). The analysis clearly shows, that flavonoids were enriched in the 
fraction eluting with 40% MeOH which we needed for the isolation of 
compounds 1-7 (Fig. 5, 7, and 31).  
 
 
 
Moreover, CPC or CC derived fractions (Fig. 7, p. 23) were unified according to 
their similarity in the TLC-fingerprint obtained after analysis in system 1 (Fig. 10 
and 11). 
 
 
 
 
Fig. 10 TLC analysis of the OWE (chapter 2.2.1, p. 19), the unified fractions 
1-19 and the residue obtained by CPC (chapter 2.2.3, p. 20 and publication 2 
[22] chapter 3.1. pp. 30-85) applying system 1 (chapter 2.3.1, p. 24 table 3) 
detected with natural product reagent/PEG 400, UV 366 nm 
1     2    3    4     5 
   OWE                                                fractions 1-19                                       residue 
Fig. 9 TLC analysis of OWE (1) (chapter 2.2.1, p. 19) and 
fractions obtained by SPE eluting with H2O (2), 10% MeOH (3), 
40% MeOH (4), and 100% MeOH (5) applying system 1 
(chapter 2.3.1 p.24, table 3) detected with natural product 
reagent/PEG 400, UV 366 nm 
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Fig. 11 TLC analysis of the unified fraction 73-81 obtained by CC of the OWE (chapter 2.2.1, p. 
19) on polyamide (chapter 2.2.4, p. 21 and publication 2 [22] chapter 3.1. p. 30-85) and further 
fractions thereof obtained by CC on Sephadex LH 20 (chapter 2.2.4, p. 21 and publication 2 [22] 
chapter 3.1. p. 30-85, Fig. 6, p. 21 and Fig. 7, p. 23) applying system 1 (chapter 2.3.1 p. 24, 
table 3) detected with natural product reagent/PEG 400, UV 366 nm 
 
For the analysis of the flavonoid aglycones in samples a-e (Table 1, p. 19) a 
more apolar system (system 2, chapter 2.3.1 p. 24, table 3) was used (Fig. 12). 
According to TLC-analysis samples c, d, and e contained the aglycones 
apigenin, luteolin, and chrysoeriol. This was confirmed by HPLC-analysis 
(publication 2 [22], chapter 3.1. p. 29-85). 
 
 
 
73-81                               5       6     7      8       9                  73-81 
     c      d       e       a       1       2       3      4 
Fig. 12 TLC analysis of the OWE 
(chapter 2.2.1, p. 19) of samples a, c, d, 
and e in comparison to the reference 
substances luteolin (1), apigenin (2), 
kaempferol (3), and chrysoeriol (4) 
applying system 2 (chapter 2.3.1 p. 24, 
table 3) detected with natural product 
reagent/PEG 400, UV 366 nm 
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For the identification of monosaccharides in the OWE of sample a and for the 
identification of the glycosidic part of isolated compounds after acid hydrolysis a 
third TLC-system was applied (system 3, chapter 2.3.1 p. 24, table 3). 
Comparison with reference substances led to the identification of glucose, 
fructose and saccharose in the OWE of sample a (Fig. 13a), which was also 
confirmed by GC-MS analyses. The sugar moieties of three isolated flavonoid 
glycosides were identified as glucose, galactose, and rhamnose (Fig. 13b). The 
results obtained by TLC were confirmed by GC-MS (chapter 3.4.3, pp. 147-150). 
 
                                    
 
 
1      2      3      4       5      6      7            8 9    10   6     2     1     3 
Fig. 13a (left) TLC analysis of the OWE (chapter 2.2.1, p. 19) of sample a (7) and the 
aqueous fraction obtained by SPE (8) in comparison to the reference substances arabinose 
(1), galactose (2), rhamnose (3), saccharose (4), fructose (5), and glucose (6) applying 
system 3 (chapter 2.3.1 p. 24, table 3) detected with diphenylamine-aniline-reagent after 
heating to 105-110°C 
 
Fig. 13b (right) TLC analysis of the aqueous fraction of compound 6 (9) and the mixture of 
compounds 1+2 (10) after acid hydrolysis (chapter 2.3.3. p. 25) in comparison to the 
reference sugars glucose (6), galactose (2), arabinose (1), and rhamnose (3) applying 
system 3 (chapter 2.3.1 p. 24, table 3) detected with diphenylamine-aniline-reagent after 
heating to 105-110°C 
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3.4.2 Optimization of HPLC-methods 
 
HPLC was employed for the qualitative and quantitative analysis of OWEs and 
fractions of D. versicolor. We hyphenated this technique with DAD or MS and 
developed suitable methods according to the respective analytical question.  
 
3.4.2.1 Establishment of an analytical HPLC-method 
 
For the method development the OWE of sample a (Table 1, p. 19) which 
served for the isolation of compounds 1-7 (Fig. 31, p. 152) was chosen. 
Throughout the method development various parameters such as stationary 
phase, linear gradient and temperature were varied. Based on the results of 
TLC analysis, which revealed the presence of flavonoid glycosides, for first 
experiments an RP-18e column (LiChrospher® 100 RP-18e, 250 x 4.6 mm, 5 
µm particles) was chosen. But even very flat gradients with a starting 
concentration of 0% organic solvent (B) did not result in a satisfactory resolution 
(Fig. 14). 
 
0 10 20 30 40 50 60 70 80 90 min
0
50
100
150
200
mAU
330nm,4nm (1.00)
 
 
 
The second tested stationary phase was Phenomenex® Luna-Phenyl-hexyl (250 
x 2.1 mm, 5µm particles), which should facilitate special interactions between 
the aromatic part of the analytes and the phenyl-rests of the stationary phase 
Fig. 14 HPLC analysis of the OWE (sample a, chapter 2.2.1, p. 19) on LiChrospher ® 100 
RP-18e applying the following linear gradient: 0→15 % B within 30 min, 15% isocratic for 20 
min, 15→40% B within 25 min, 40→100% B within 10 min at a flow rate of 1mL/min and a 
column oven temperature of 25°C; detected at 330nm  
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and, therefore, provide a better separation. This column showed better results 
than the RP-18e column but there was still need for improvement (Fig. 15). 
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In order to overcome this problem the column oven temperature was changed 
to values above and below room temperature (Fig. 16).  
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In general, higher temperatures shortened the retention times, whereas lower 
temperatures delayed the elution of the compounds. The experiments showed 
that a temperature of 15°C led to a good separation of the compound eluting 
Fig. 16 HPLC analysis of the OWE (sample a, chapter 2.2.1, p. 19) on Phenomenex® Luna 
Phenyl-hexyl applying the following linear gradient: 0→10% B within 20 min, 10→12% 
within 5 min, 12→20% B within 60 min, 20→100% B within 10 min at a flow rate of 0.2 
mL/min and various column oven temperatures; detected at 340nm  
Fig. 15 HPLC analysis of the OWE (sample a, chapter 2.2.1, p. 19) on Phenomenex® Luna 
Phenyl-hexyl applying the following linear gradient: 0→10% B within 20 min, 10→12% 
within 5 min, 12→20% B within 60 min, 20→100% B within 10 min at a flow rate of 0.2 
mL/min and a column oven temperature of 25°C; detected at 330nm  
15 °C 
20 °C 
28 °C 
35 °C 
40 °C 
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after 62-63 min from those eluting earlier, but the resolution of all other 
compounds was bad. On the other hand, higher temperatures (up to 40°C) 
resulted in a good separation of the compound eluting at 39 min. The optimal 
oven temperature for using this column seemed to be 28 °C.  
Nevertheless, the separation on Luna-Phenyl-hexyl was not satisfying, and 
therefore, a third column, Aquasil® C18 (250 x 4.6 mm, 5 µm particles), was 
tested. This stationary phase is characterized by C18 chains with polar 
embedded groups and should therefore be suitable for the separation of polar 
compounds. Indeed, this column showed the best results (Fig.17). 
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The next step was the optimization of the linear gradient. Based on the trials on 
RP-18e and phenyl-hexyl material a starting concentration of 0% of solvent B 
was chosen and the steepness of the gradient was gradually decreased 
Fig. 17 HPLC analysis of the OWE (sample a, chapter 2.2.1, p. 19) on Aquasil® C 18 
applying the following linear gradient: 0→10% B within 20 min, 10→23% within 40 min, 23 
isocratic for 15 min, 23→40% B within 10 min, 40→100% B within 5 min at a flow rate of 1 
mL/min and a column oven temperature of 25°C; detected at 270 nm (upper panel) and 
330 nm (lower panel)  
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Fig. 19 HPLC analysis of the OWE (chapter 2.2.1, p. 19) and fractions thereof obtained by 
SPE (chapter 2.2.2, p. 20) on Aquasil® C 18 applying the following linear gradient: 0→10% 
B within 20 min, 10→20% within 60 min, 20→40% B within 20 min, 40→95% B within 10 
min at a flow rate of 1 mL/min and a column oven temperature of 25°C; detected at 340 nm 
resulting in the following optimal composition: 0% B to 10% B within 20 min 
(rate: 0.5%/min), 10% B to 20% B within 60 min (rate: 0.17%/min), 20% B to 
40% B within 20 min (rate: 1%/min) and finally from 40% B up to 95% B within 
10 min (rate: 5.5%/min) (Fig. 18). 
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This method was used for the qualitative analysis of fractions obtained by SPE 
(Fig. 19), CPC, and CC and for the semipreparative isolation of compunds 1-7 
(Fig. 20-23). 
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Fig. 18 HPLC analysis of the OWE (chapter 2.2.1, p. 19) on Aquasil® C 18 applying the 
following linear gradient: 0→10% B within 20 min, 10→20% within 60 min, 20→40% B 
within 20 min, 40→95% B within 10 min at a flow rate of 1 mL/min and a column oven 
temperature of 25°C; detected at 340 nm 
OWE 
H2O fraction 
10% MeOH 
40% MeOH 
100% MeOH 
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Fig. 20 HPLC analysis of the fraction “residue” (Fig. 7, chapter 2.2.3, p. 23 and 
publication 2 [22] chapter 3.1. p. 30-85) on Aquasil® C 18 applying the following linear 
gradient: 0→10% B within 20 min, 10→20% within 60 min, 20→40% B within 20 min, 
40→95% B within 10 min at a flow rate of 1 mL/min and a column oven temperature of 
25°C; detected at 330 nm; 
Fig. 21 HPLC analysis of fraction I (35-42) (Fig. 7, chapter 2.2.4, p. 23) on Aquasil® C 18 
applying the following linear gradient: 0→10% B within 20 min, 10→20% within 60 min, 
20→40% B within 20 min, 40→95% B within 10 min at a flow rate of 1 mL/min and a 
column oven temperature of 25°C; detected at 270 and 340 nm; 
 
Fig. 20 shows the HPLC analysis of the fraction “residue” (Fig. 7, chapter 2.2.3, 
p. 23 and publication 2 [22], chapter 3.1. p. 30-85). It served for the isolation of 
compounds 1 and 2 by semipreparative HPLC (publication 2 [22], chapter 3.1. p. 
30-85) 
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Fig. 21 shows the HPLC analysis of fraction I (35-42) (Fig. 7, chapter 2.2.4, p. 
23 and publication 2 [22] chapter 3.1. p. 30-85), which served for the isolation of 
the isobaric compounds 3a, 3b and 4a, 4b (publication 2 [22], chapter 3.1. p. 
30-85). 
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Fig. 22 HPLC analysis of fractions 2-6 (Fig. 7, chapter 2.2.4, p. 23) on Aquasil® C 18 
applying the following linear gradient: 0→10% B within 20 min, 10→20% within 60 min, 
20→40% B within 20 min, 40→95% B within 10 min at a flow rate of 1 mL/min and a 
column oven temperature of 25°C; detected at 340 nm 
Fig. 23 HPLC analysis of fractions 5-9 (Fig. 7, p. 23) on Aquasil® C 18 applying the 
following linear gradient: 0→10% B within 20 min, 10→20% within 60 min, 20→40% B 
within 20 min, 40→95% B within 10 min at a flow rate of 1 mL/min and a column oven 
temperature of 25°C; detected at 340 nm 
Fig. 22 shows the HPLC analysis of fractions 2-6 obtained by CC of fraction II 
(50-55) (Fig. 7, p. 23) on Sephadex LH-20. Fractions 3, 4, and 5 served for the 
isolation of compound 5 (red ring) by semipreparative HPLC (publication 2 [22], 
chapter 3.1. p. 30-85). 
 
Fig. 23 shows the HPLC analysis of fractions 5-9 obtained by CC of fraction V 
(73-81) (Fig. 7, chapter 2.2.4, p. 23) on Sephadex LH-20. These fractions 
served for the isolation of compound 6 (black ring) by semipreparative HPLC 
(publication 2 [22], chapter 3.1. p. 30-85). 
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Fig. 24 HPLC analysis of the OWE (chapter 2.2.1, p. 19) on Aquasil® C 18 applying the 
following linear gradient: 0→10% B within 20 min, 10→20% within 60 min, 20→40% B 
within 20 min, 40→95% B within 10 min at a flow rate of 1 mL/min and column oven 
temperature of 15 and 25°C; detected at 340 nm 
Even though the separation of the flavonoid glycosides contained in the OWE of 
sample a seemed to be satisfying LC-MS analyses carried out later showed that 
the peak eluting at 66 min was a mixture of at least two compounds.  
As described before variations on column oven temperature were performed at 
15°C and 25°C (Fig. 24). 
 
 
 
According to those analyses a column oven temperature of 15°C showed an 
acceptable separation, which provides the possibility to quantify single 
compounds. A comparison of the OWEs of samples a-e led to the conclusion 
that the application of this method was useful only for the quantification of 
flavonoids in the OWE and the crude drug of sample a. This application using 
rutoside as internal standard is described in publication 4 [24], pp. 113-125. 
Furthermore, a disadvantage was the quite long time of analysis (121 min). 
Therefore, the dimensions of the Aquasil® C 18 column were changed from 250 
x 4.6 mm, 5µm particles to 150 x 2.1 mm, 3µm particles in order to shorten the 
retention times. As a consequence of the change in column parameters the 
linear gradient and the flow rate had to be optimized. After a couple of trials the 
following parameters provided an acceptable separation at a reasonable 
duration for qualitative analyses within 51 min: 2% B to 14% B within 23 min 
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Fig. 25 HPLC analysis of the OWE (chapter 2.2.1, p. 19) on Aquasil® C 18 (3µm 
particles) applying the following linear gradient: 2→14% B within 23 min followed by an 
isocratic period of 23 min at a flow rate of 0.35 mL/min and column oven temperature of 
15°C; detected at 270 and 340 nm 
(rate: 0.52%/min), followed by an isocratic period of 27 min (Fig. 25). The flow 
rate of 0.35 mL/min allowed direct coupling to MS and reduced the consumption 
of solvents by 86%. 
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Unfortunately, for the quantification of single compounds the resolution was not 
sufficient for all compounds.  
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Fig. 26 HPLC analysis of the OWEs (chapter 2.2.1, p. 19) of samples a, c, d, and e on 
Aquasil® C 18 (5µm particles) applying the following linear gradient: 0→10% B within 20 
min, 10→20% within 60 min, 20→40% B within 20 min, 40→95% B within 10 min at a 
flow rate of 1 mL/min and column oven temperature of 15°C; detected at 340 nm 
Fig. 27 HPLC analysis of the OWEs (chapter 2.2.1, p. 19) of samples a-e on Aquasil® C 
18 (5µm particles) applying the following linear gradient: 15→23.75% B within 58 min, 
23.75→29% within 15 min at a flow rate of 1 mL/min and a column oven temperature of 
15°C; detected at 340 nm 
3.4.2.2 Quantification of flavonoids by HPLC-UV 
 
A comparison of the OWEs of samples a, c, d, and e showed that the method 
described in publication 4 [24] was not suitable for all samples (Fig. 26).  
 
 
For this, a method which has been developed for analysis of sample c [30] was 
adopted by varying the gradient and the column oven temperature (Fig. 27).  
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Fig. 28 GC-MS analysis of the diastereomeric butylglycosidic residues of compound 
4a+4b (pink curve) in comparison to the identically treated references rutoside (black 
curve) and hyperoside (blue curve) according to the method described in publication 2 
[22] (chapter 3.1. p. 30-85)  
 
This newly developed gradient is a compromise providing separation of most of 
the compounds, although with rather low resolution for some peak pairs, at 
acceptable retention times and is described in publication 3 [23] (chapter 3.2, pp. 
87-112). 
 
3.4.3 Determination of sugar moieties 
 
GC-MS analyses after acid hydrolysis with Kiliani reagent (chapter 2.3.3. p. 25) 
led to the assessment of the absolute configuration of the monosaccharides 
which is described in detail in publication 2 (chapter 3.1. pp. 30-85). This 
technique had been applied successfully before for the determination of sugar 
moieties in saponins [32] and phenolic derivatives [33]. Fig. 28 shows the GC-
MS analysis of the diastereomeric butylglycosidic residues of compound 4a+4b 
in comparison to the identically treated reference substances rutoside and 
hyperoside (quercetin-3-O-galactoside) containing D-glucose, D-galactose, and 
L-rhamnose. 
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Furthermore, the exact linkage of the sugar units within the disaccharide moiety 
of the isolated compounds was determined following the method described in 
chapter 2.3.3, p 25. According to the nomenclature of specific fragment series 
developed by Kochetkov and Chizov [34, 35] the intensities of the J, F/G, H, 
and K series were compared. The fragments show different molecular masses 
depending on their substituent which can either be an –OCH3 or –OTMS 
residue, and the most intensive fragment in each of these series represents the 
substituent of a particular carbon atom [26]. Furthermore, after hydrolysis the 
equilibrium of the two anomeric forms of a monosaccharide is reached resulting 
in the appearance of peak pairs in the chromatogram. The ratio of the peak 
areas of the two corresponding peaks is characteristic e.g. the ratios for 2,3,4-
tetramethyl-1,6-TMS-glucose and 2,3,4-tetramethyl-1,6-TMS-galactose are 
almost 1:1, whereas 2,3,4-Tetramethyl-1-TMS-rhamnose shows a main peak 
eluting prior to a very small second peak (ratio almost 90:10). Mixtures of the 
compounds 1+2, 3a+3b and 4a+4b were analyzed using rutoside as a 
reference substance. Fig. 29, p. 149 (upper panel) shows the total ion current 
(TIC, black) and the extracted ion currents (EIC) m/z 88 (pink, -OCH3 at C2 and 
C3), m/z 101 (blue, -OCH3 at C2 and C4), and m/z 133 (brown, -OTMS at C1 and 
–OCH3 at C3). The mass spectra of the derivatized monosaccharides appearing 
as peak pairs at 17.7 /17.9 min and 26.1/26.6 min are shown in Fig. 29 (middle 
and lower panel) and confirm the above mentioned fragments as the most 
abundant of the respective series of rhamnosyl-1→6-glucoside representing the 
glycosidic part of rutoside.  
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Fig. 29 GC-MS analysis of rutoside, treated according to the method described in 
chapter 2.3.3, p. 25 showing the TIC and EIC (upper panel) and the EI-MS spectra of the 
compounds eluting at 17.7 min (middle panel) and 26.1 min (lower panel) 
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The GC-MS analysis of the derivatized sugar units of compounds 1 and 2 is 
shown in Fig. 30. The chromatogram shows peak pairs at retention times 
identical to those of 2,3,4-tetramethyl-1-TMS-rhamnose (tR=17.8/18.1 min) and 
2,3,4-tetramethyl-1,6-TMS-glucose (tR=26.1/26.6), obtained from the reference 
rutoside. The ratios of the peak areas of the two anomers are in accordance 
with literature [27] and suggest a 1→6 linkage for the rhamnosyl-glucoside of 
compound 1. The peaks appearing at (tR=22.7/23.1) are supposed to be 2,3,4-
tetramethyl-1,6-TMS-galactose and suggest a 1→6 linkage for the rhamnosyl-
galatoside in compound 2. 
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Fig. 30 GC-MS analysis of compounds 1+2, treated according to the method described 
in chapter 2.3.3, p. 25 showing EIC (upper panel) and the EI-MS spectra of the 
compounds eluting at 17.8 min, 22.7 min, and 26.1 min (lower panels)  
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The mixtures of 3a+3b and 4a+4b showed identical patterns to those obtained 
for compounds 1+2. The above described results were confirmed by HMBC 
analyses (publication 2 [22], chapter 3.1. pp. 30-85). 
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4 Discussion and conclusion 
 
Dianthus versicolor is a plant used traditionally in Mongolian medicine against 
liver impairments. As traditional medicine has become more important since the 
last two decades in Mongolia, increasing scientific research is required to prove 
the efficacy of the therapeutic methods and the medicinal plants applied to 
patients. In cooperation between the HSUM, the Department of Pharmacognosy 
of the University of Vienna and the Medical University of Vienna the plant was 
investigated for its bile flow stimulating activities. An aqueous extract, specially 
prepared according to the traditional way of intake, was examined in the model 
of the isolated perfused rat liver in concentrations of 100, 250, and 500 mg/L. It 
caused an increase of the bile salt independent bile flow (hydrocholeresis) 
showing a slight dose dependency. The bile salt dependent bile flow remained 
unaffected. In order to locate the active principles the extract was subsequently 
fractionated by SPE and two of the resulting fractions, one enriched in 
flavonoids and one enriched in sugars were tested in the model. The flavonoid 
enriched fraction, tested in concentrations of 10, 20, and 40 mg/mL, increased 
the bile flow, which was comparable to the positive control cynarin, a dicaffeoyl-
quinic-acid well known for choleretic activity [12, 36]. On the other hand, the 
sugar fraction did not show any effect. It is known that choleretic plant extracts, 
e.g. from yarrow and artichoke, are beneficial for the treatment of digestive 
problems related to a reduced function of liver and bile flow [37, 38, 39]. 
Therefore, our findings could explain, at least in part, the beneficial effects of 
this plant on patients treated with traditional preparations. Furthermore the 
flavonoids are suggested to contribute substantially to the effect on the bile flow. 
Indeed, flavonoids e.g. apigenin-7-O-glucoside, which is contained in choleretic 
plants e.g. Achillea millefolium s.l., Cynara scolymus, Saussurea amara have 
been shown to increase the bile flow in this model before [12, 39, 40, 41]. 
However, it has to be kept in mind that the applied test system is an ex vivo 
model and further in vivo studies are required to confirm these results.  
 
Further phytochemical investigations were focussed on the flavonoids. The SPE 
derived 40% MeOH fraction was fractionated by CPC, and one of those 
fractions, purified by semipreparative HPLC led to the isolation of isoorientin-7-
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Fig. 31 Structures of the isolated compounds 1-7; Glc: glucose, Gal: galactose, Rha: 
rhamnose 
O-rutinoside (1) and isoorientin-7-O-rhamnosyl-glactoside (2). Furthermore, the 
OWE was fractionated via CC on Polyamide. Fractions thereof were 
subsequently fractionated on Sephadex LH-20 and finally purified by 
semipreparative HPLC. This resulted in the isolation of isovitexin-7-O-rutinoside 
(3a), isovitexin-7-O-rhamnosyl-galactoside (3b), isoscoparin-7-O-rutinoside (4a), 
isoscoparin-7-O-rhamnosyl-galactoside (4b), isoscoparin-7-O-galactoside (5), 
isoorientin-7-O-galactoside (6), and isovitexin-7-O-glucoside (7) (Fig. 31).  
 
 
 
 
 
 
Their structures were matched multidimensionally on the basis of extensive 
spectroscopic and spectrometric investigations including LC-DAD, LC-MSn, LC-
HR-ESI-MS, 1D and 2D NMR, and by GC-MS analysis after hydrolysis. 
Especially the structure elucidation of 3a and 3b, as well as 4a and 4b was 
challenging, because the compounds were obtained as mixtures of the isobaric 
forms, differing only in the nature of the 7-O-attached hexose. The occurrence 
of two or three sugar moieties within one molecule and the relatively small 
sample amounts (1.5 - 4.5 mg) made the interpretation of the NMR spectra 
rather difficult. In order to support the identification of sugar moieties and the 
linkage of monosaccharides within the molecules GC-MS after hydrolysis of the 
permethylated flavonoid glycosides was employed. The method was applicable 
also to even less than 1 mg of compound. The isolated compounds are all C- 
and O-glycosides, which is rather rare within the genus Dianthus, according to 
 R R1 R2 Common name 
1 OH Glc Rha(16)Glc Isoorientin-7-O-rutinoside 
2 OH Glc Rha(16)Gal Isoorientin-7-O-rhamnosyl-galactoside 
3a H Glc Rha(16)Glc Isovitexin-7-O-rutinoside 
3b H Glc Rha(16)Gal Isovitexin-7-O-rhamnosyl-galactoside 
4a OCH3 Glc Rha(16)Glc Isoscoparin-7-O-rutinoside 
4b OCH3 Glc Rha(16)Gal Isoscoparin-7-O-rhamnosyl-galactoside 
5 OCH3 Glc Gal Isoscoparin-7-O-galactoside 
6 OH Glc Gal Isoorientin-7-O-galactoside 
7 H Glc Glc Isovitexin-7-O-glucoside (saponarin) 
O
O
OH
R
R2O
OH
R1
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the available phytochemical literature [22]. Among the isolated compounds 
isovitexin-7-O-glucoside (7) and isovitexin-7-O-rutinoside (3a) are well known 
compounds and have been isolated before [42, 43]. Isoorientin-7-O-rutinoside 
(1) has also been mentioned in literature [44], but it is the first time, that full 
NMR data and the absolute configuration of the sugar moieties is presented. 
The other compounds are isolated and structurally elucidated for the first time. 
Furthermore the known flavonoid-glycosides isovitexin-2''-O-rhamnoside, 
isovitexin, apigenin-7-O-glucoside, luteolin-7-O-glucoside, apigenin, luteolin, 
chrysoeriol, diosmetin, and acacetin were identified [30]. None of those 
compounds has been described for D. versicolor so far.  
 
In order to establish analytical methods, which could serve as tool for quality 
control of this traditionally used Mongolian drug, different samples of D. 
versicolor were compared. The samples were collected in different years and 
different locations in Mongolia. Aqueous extracts were prepared and analyzed 
by TLC and HPLC. All of them showed a qualitatively similar flavonoid 
fingerprint but revealed differences in the quantity of flavonoids. For the 
quantification of the flavonoid glycosides an HPLC-DAD method was developed 
and validated concerning linearity, accuracy, and precision using isovitexin-7-O-
glucoside as external standard. This method allows the determination of the 
content of single compounds as well as the total flavonoid content and showed 
total flavonoid contents ranging from 0.41 % to 3.30 % for the analyzed samples. 
Samples a and b contained an exclusively high content of polar flavonoid-di- 
and -triglycosides. The HPLC method described above can be seen as 
compromise providing an acceptable separation within a reasonable time of 
analysis. In order to reach a better separation of the polar compounds, an 
alternative method was developed and validated using rutoside as internal 
standard. Showing good linearity, accuracy, and precision this method is 
suitable for the analysis of samples containing very polar compounds. Finally, a 
quite simple UV-spectrophotometric method, based on the European 
pharmacopoeia monograph of “Passiflorae herba”, was modified for the 
determination of the total flavonoid content of D. versicolor. The crude drug of 
sample a, the respective aqueous extract, and the flavonoid enriched fraction 
were compared, and correlation between the total flavonoid contents assessed 
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by HPLC and UV-spectrophotometry was found. Therefore, the methods 
described in this thesis can be regarded as basic methods for quality control of 
this traditional Mongolian drug. 
 
The results obtained from the tests on isolated organ preparations (uterus, 
papillar muscle, arteria pulmonalis, aorta, and terminal ileum) must be seen as 
preliminary, although the observed uterus constringing potential seems to relate 
to the indications described by Ligaa [15]. However, flavonoids are not 
responsible for these findings, because they are known for their spasmolytic 
activity, and a lot of medicinal plants, e.g., yarrow, chamomile, are used for this 
beneficial effect [37]. Therefore, other polar ingredients must be the active 
principle and should be further investigated. 
 
To conclude, this work provides first phytochemical investigations on the 
traditional Mongolian medicinal plant D. versicolor. With regard to the traditional 
use for the treatment of liver disorders the focus was put on the analysis of 
flavonoids, which contribute to the beneficial effect. The qualitative and 
quantitative analyses applying various chromatographic, spectrometric, and 
spectroscopic techniques allowed a comprehensive phytochemical 
characterization of this plant and led to the isolation and structural elucidation of 
new compounds. However, the flavonoids represent only one class of 
compounds contained in the complex mixture of this plant’s extract. Therefore, 
further investigations are encouraged. 
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5 Summary 
 
The aim of this thesis was the phytochemical investigation of the Mongolian 
medicinal plant Dianthus versicolor accompanied by the testing for its activity on 
the bile flow. It is used in traditional medicine for various indications, among 
them for the treatment of liver and gastrointestinal disorders.  
An aqueous extract, prepared according to the traditional way of intake, was 
tested in the model of the isolated perfused rat liver in order to examine its 
influence on the bile flow. Different concentrations led to an increase of the bile 
flow showing a slight dose dependency. The extract was subsequently 
fractionated by solid phase extraction and one of the fractions, enriched in 
flavonoids showed an influence on the bile flow. This effect was comparable to 
the positive control cynarin, which is known for its cholerectic activity. 
Furthermore, the extract was examined on isolated organ preparations from the 
uterus, aorta, heart, arteria pulmonalis and terminal ileum and showed a uterus-
constringing activity. 
Further fractionation of the enriched flavonoid fraction by centrifugal partition 
chromatography or column chromatography and purification by semipreparative 
HPLC led to the isolation of nine flavonoid-C- and O-glycosides. Their 
structures were established on the basis of extensive spectroscopic and 
spectrometric investigations including LC-DAD, LC-MSn, LC-HR-ESI-MS, 1D 
and 2D NMR, and by GC-MS analysis after hydrolysis. Seven of the isolated 
structures are new, and have not been described for D. versicolor so far. 
For the quantification of the flavonoids different HPLC-DAD methods were 
established and validated using external or internal standards. As alternative a 
quite simple UV-spectrophotometric method was developed. It based on a 
monograph from the European Pharmacopoeia and was slightly modified, 
showing comparable data to those obtained from HPLC-DAD analysis. 
 
The qualitative and quantitative analyses allowed a detailed phytochemical 
characterization of the flavonoids contained in the aqueous extract of this plant 
and led to the isolation and structural elucidation of new compounds. 
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6 Zusammenfassung 
 
Das Ziel dieser Arbeit war die phytochemische Untersuchung der mongolischen 
Arzneipflanze Dianthus versicolor, die in der tradtionellen Medizin gegen 
Lebererkrankungen und gastrointestinale Beschwerden verwendet wird. 
Unterschiedliche Konzentrationen eines wässrigen Extraktes führten im Modell 
der isolierten perfundierten Rattenleber zu einer Steigerung des Gallenflusses, 
was als Hinweis auf eine Stimulierung der Leber gesehen werden kann. In 
weiterer Folge wurde das Extrakt aktivitätsgeleitet fraktioniert, wobei eine 
flavonoidreiche Fraktion eine dem Cynarin vergleichbare choleretische Wirkung 
zeigte. Darüber hinaus wurde das wässrige Extrakt an verschiedenen 
glattmuskulären Organpräparaten getestet und wies in höherer Dosierung eine 
Uterus-kontrahierende Wirkung auf.  
 
Eine weiterführende Fraktionierung der Flavonoid-Fraktion mittels CPC, CC und 
semipräparativer HPLC resultierte in der Isolierung von neun Flavon-C- und O-
glykosiden. Die Strukturaufklärung dieser Verbindungen gelang unter 
Anwendung diverser spektroskopischer und spektrometrischer Verfahren, wie 
LC-DAD, LC-ESI-MSn, LC-HR-ESI-MS, 1D und 2D-NMR sowie GC-MS nach 
Hydrolyse. Sieben der isolierten Verbindungen sind neue Strukturen und für D. 
versicolor noch nicht beschrieben. Für die Analytik der Flavonoide wurden 
geeignete HPLC-Systeme ausgearbeitet, die die Quantifizierung mit internem 
oder externem Standard erlauben. Als Alternative zur Quantifizierung mittels 
HPLC wurde eine UV-spektrophotometrische Methode, basierend auf der 
Monographie „Passionsblumenkraut“ der Pharmacopoeia Europea, erstellt, 
welche vergleichbare Ergebnisse liefert. 
 
Die im Rahmen dieser Arbeit durchgeführten qualitativen und quantitativen 
Analysen tragen wesentlich zur Chrarakterisierung der in D. versicolor 
enthaltenen Flavonoid-Glykoside bei. Darüber hinaus gelang die Isolierung und 
Strukturaufklärung neuer Substanzen. 
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